<?xml version="1.0" encoding="UTF-8"?>
<inno:dom xmlns:inno="http://innodatalabs.com/innodom"><inno:meta/><inno:content><inno:text id="text-1" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="201.0" x-min="194.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-3-</inno:font></inno:block></inno:text><inno:text id="text-2" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="172.0" x-min="43.0" y-max="56.0" y-min="42.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Part 1 - Executive Summary</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-3" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="88.0" y-min="61.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The COVID-19 pandemic has significantly impacted the financial condition, financial performance,<inno:br/>operations and cash flows of reporting issuers of varying sizes and industries. This has specific financial<inno:br/>reporting implications for issuers.</inno:font></inno:block></inno:text><inno:text id="text-4" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="180.0" y-min="94.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">We were encouraged by the quality of disclosures provided by many issuers significantly impacted by<inno:br/>COVID-19. However, we noted certain areas where boiler-plate disclosure was provided regarding the<inno:br/>current and expected impact of COVID-19 on an issuer’s business with insufficient detail of entity-<inno:br/>specific COVID-19 related risks, including but not limited to, the nature and extent of credit risks and<inno:br/>liquidity uncertainties. We also observed instances of unbalanced or overly promotional disclosure and<inno:br/>isolated non-compliance for non-GAAP financial measures (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGM</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">s) and forward-looking information<inno:br/>(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">). It is important for issuers to tailor their disclosures to provide investors with an entity-specific<inno:br/>level of insight to understand the operational challenges, financial impacts, risk profile and the issuer’s<inno:br/>operational responses related to the COVID-19 pandemic. Such information is necessary to meet<inno:br/>securities requirements and to help foster investor confidence in the current environment.</inno:font></inno:block></inno:text><inno:text id="text-5" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="205.0" y-min="184.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The reviews have resulted in outcomes where no action was required, requests for prospective disclosure<inno:br/>enhancements were made, or communication is ongoing to resolve the identified issues.</inno:font></inno:block></inno:text><inno:text id="text-6" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="323.0" x-min="43.0" y-max="221.0" y-min="208.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">At a high level, we emphasize the following for issuers to consider in their upcoming CD filings:</inno:font></inno:block></inno:text><inno:text id="text-7" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="51.0" y-max="245.0" y-min="225.0"><inno:nec bbox="82.4 428.93 87.45 432.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">There is no “one size fits all” model for issuers to follow when assessing the disclosure<inno:br/>implications of COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-8" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="227.0" x-min="53.0" y-max="254.0" y-min="246.0"><inno:nec bbox="84.0 402.73 89.05 406.66" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Disclosures are expected to be transparent and balanced.</inno:font></inno:block></inno:text><inno:text id="text-9" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="268.0" x-min="53.0" y-max="263.0" y-min="254.1"><inno:nec bbox="84.0 389.23 89.05 393.16" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Provide disclosures on COVID-19 that facilitates an understanding of:</inno:font></inno:block></inno:text><inno:text id="text-10" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="75.0" y-max="279.0" y-min="263.1"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The current and expected impact of COVID-19 on the issuer’s operations and financial<inno:br/>condition, including liquidity and capital resources.</inno:font></inno:block></inno:text><inno:text id="text-11" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="277.0" x-min="77.0" y-max="288.0" y-min="280.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The key risks that the COVID-19 pandemic presents to the issuer.</inno:font></inno:block></inno:text><inno:text id="text-12" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="313.9" y-min="289.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Known trends, demands, events or uncertainties related to COVID-19 that management<inno:br/>reasonably believes will materially affect the issuer’s future revenues, expenses or<inno:br/>projects.</inno:font></inno:block></inno:text><inno:text id="text-13" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="330.0" y-min="314.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The operational changes and other measures taken by management in response to<inno:br/>COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-14" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="355.9" y-min="330.1"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">How COVID-19 has impacted the issuer’s capacity to meet working capital<inno:br/>requirements, debt covenants, planned growth or funding of future development activities<inno:br/>and capital expenditures.</inno:font></inno:block></inno:text><inno:text id="text-15" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="373.0" y-min="356.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">How the COVID-19 pandemic has impacted areas of financial reporting subject to<inno:br/>significant judgement and measurement uncertainty in the current environment.</inno:font></inno:block></inno:text><inno:text id="text-16" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="404.9" y-min="373.1"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">How the issuer has assessed impairment of non-financial assets given the extended<inno:br/>impact of the COVID-19 pandemic. Where applicable, sensitivity analysis and<inno:br/>disclosures relating to key assumptions will be especially important and should be both<inno:br/>realistic and supportable.</inno:font></inno:block></inno:text><inno:text id="text-17" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="345.0" x-min="76.0" y-max="425.0" y-min="405.0"><inno:font font-name="CourierNewPSMT" font-size="12.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The accounting policy for, and nature and extent of government grants recognized in the<inno:br/>financial statements.</inno:font></inno:block></inno:text><inno:text id="text-18" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="189.0" x-min="43.0" y-max="447.0" y-min="432.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Part 2 - Scope and Methodology</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-19" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="472.0" y-min="451.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Staff took a risk-based approach in the selection of issuers by considering both qualitative and<inno:br/>quantitative criteria. Issuers selected for review included those identified as being materially impacted</inno:font></inno:block></inno:text><inno:text id="text-20" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="201.0" x-min="193.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-4-</inno:font></inno:block></inno:text><inno:text id="text-21" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="39.0" y-max="62.0" y-min="41.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(both positively and adversely) by the COVID-19 pandemic in terms of their operations and financial<inno:br/>performance, as well as issuers that appeared to have a higher risk of impairment and/or financial distress.</inno:font></inno:block></inno:text><inno:text id="text-22" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="39.0" y-max="95.0" y-min="65.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Staff examined the CD filings of approximately 90 issuers, focusing on the disclosures of the most recent<inno:br/>interim reporting period ending September 30, 2020 for issuers with a calendar financial year end. The<inno:br/>issuers selected for review varied by size and by industry as illustrated in the charts below:</inno:font></inno:block></inno:text><inno:text id="text-23" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="73.0" x-min="39.0" y-max="108.0" y-min="100.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Figure #1</inno:font></inno:b></inno:block></inno:text><inno:image id="image-1" type="image"><inno:block page="2" page-height="512" page-width="396" x-max="350.0" x-min="44.0" y-max="225.0" y-min="113.0"/></inno:image><inno:text id="text-24" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="39.0" y-max="273.0" y-min="229.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Our reviews primarily focused on issuers’ disclosure obligations under National Instrument 51-102</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Continuous Disclosure Obligations</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NI 51-102</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">). We also assessed compliance with certain recognition,<inno:br/>measurement and disclosure requirements in International Financial Reporting Standards (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">IFRS</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) and<inno:br/>compliance with CSA Staff Notice 52-306</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>(Revised) – Non-GAAP Financial Measures</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">SN 52-306</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">). The<inno:br/>following outlines the focus areas of the reviews conducted:</inno:font></inno:block></inno:text><inno:text id="text-25" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="107.9" x-min="39.0" y-max="464.0" y-min="273.1"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">MD&amp;A<inno:br/>Financial<inno:br/>Statements<inno:br/>Other</inno:font></inno:b></inno:block></inno:text><inno:text id="text-26" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="96.0" x-min="52.0" y-max="480.0" y-min="464.1"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Regulatory<inno:br/>Requirements</inno:font></inno:b></inno:block></inno:text><inno:text id="text-27" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="264.0" x-min="109.0" y-max="294.0" y-min="279.0"><inno:nec bbox="170.5 341.63 175.55 345.56" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Overall performance and discussion of operations</inno:font></inno:color></inno:block></inno:text><inno:text id="text-28" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="237.0" x-min="112.1" y-max="302.9" y-min="294.1"><inno:nec bbox="170.5 328.13 175.55 332.06" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Known trends, events and uncertainties</inno:font></inno:color></inno:block></inno:text><inno:text id="text-29" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="214.0" x-min="108.0" y-max="310.0" y-min="303.0"><inno:nec bbox="170.5 314.63 175.55 318.56" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Liquidity and capital resources</inno:font></inno:color></inno:block></inno:text><inno:text id="text-30" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="168.0" x-min="112.1" y-max="320.0" y-min="312.0"><inno:nec bbox="170.5 301.13 175.55 305.06" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Debt covenants</inno:font></inno:color></inno:block></inno:text><inno:text id="text-31" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="185.0" x-min="108.0" y-max="333.0" y-min="321.0"><inno:nec bbox="170.5 287.63 175.55 291.56" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Risk factor disclosure</inno:font></inno:color></inno:block></inno:text><inno:text id="text-32" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="221.0" x-min="109.0" y-max="363.9" y-min="356.0"><inno:nec bbox="170.5 232.23 175.55 236.16" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Impairment of non-financial assets</inno:font></inno:color></inno:block></inno:text><inno:text id="text-33" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="167.0" x-min="110.0" y-max="373.0" y-min="364.0"><inno:nec bbox="170.5 218.73 175.55 222.66" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Going concern</inno:font></inno:color></inno:block></inno:text><inno:text id="text-34" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="277.0" x-min="109.0" y-max="381.9" y-min="374.0"><inno:nec bbox="170.5 205.23 175.55 209.16" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Significant judgements and measurement uncertainties</inno:font></inno:color></inno:block></inno:text><inno:text id="text-35" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="188.0" x-min="112.0" y-max="391.0" y-min="382.0"><inno:nec bbox="170.5 191.73 175.55 195.66" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Expected credit losses</inno:font></inno:color></inno:block></inno:text><inno:text id="text-36" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="251.0" x-min="110.0" y-max="399.0" y-min="391.1"><inno:nec bbox="170.5 178.23 175.55 182.16" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Fair value changes for the real estate industry</inno:font></inno:color></inno:block></inno:text><inno:text id="text-37" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="227.0" x-min="112.1" y-max="405.9" y-min="400.0"><inno:nec bbox="170.5 164.73 175.55 168.66" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Financial instrument risk disclosures</inno:font></inno:color></inno:block></inno:text><inno:text id="text-38" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="189.0" x-min="111.0" y-max="416.0" y-min="406.0"><inno:nec bbox="170.5 151.23 175.55 155.16" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Government assistance</inno:font></inno:color></inno:block></inno:text><inno:text id="text-39" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="298.0" x-min="109.0" y-max="426.0" y-min="417.0"><inno:nec bbox="170.5 137.73 175.55 141.66" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">COVID-19 related amendments to IFRS 16</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Leases</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">for lessees</inno:font></inno:color></inno:block></inno:text><inno:text id="text-40" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="144.0" x-min="108.0" y-max="457.0" y-min="444.0"><inno:nec bbox="171.1 87.93 176.15 91.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">NGMs</inno:font></inno:color></inno:block></inno:text><inno:text id="text-41" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="133.0" x-min="110.0" y-max="466.0" y-min="458.0"><inno:nec bbox="171.1 74.43 176.15 78.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">FLI</inno:font></inno:color></inno:block></inno:text><inno:text id="text-42" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="195.0" x-min="109.0" y-max="476.9" y-min="468.0"><inno:nec bbox="171.1 60.93 176.15 64.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Material change reporting</inno:font></inno:color></inno:block></inno:text><inno:text id="text-43" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="192.0" x-min="110.0" y-max="485.0" y-min="477.0"><inno:nec bbox="171.1 47.43 176.15 51.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Promotional disclosures</inno:font></inno:color></inno:block></inno:text><inno:text id="text-44" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="201.0" x-min="193.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-5-</inno:font></inno:block></inno:text><inno:text id="text-45" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="249.0" x-min="42.0" y-max="75.0" y-min="62.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Part 3 - Summary of Results and Key Themes</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-46" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="324.0" x-min="42.0" y-max="100.0" y-min="81.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Our reviews covered a variety of industries and highlighted the diverse impacts of the COVID-19<inno:br/>pandemic on issuers’ operations and businesses. Some of these impacts included:</inno:font></inno:block></inno:text><inno:image id="image-2" type="image"><inno:block page="3" page-height="512" page-width="396" x-max="349.0" x-min="42.0" y-max="258.0" y-min="107.0"/></inno:image><inno:text id="text-47" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="319.0" x-min="42.0" y-max="284.0" y-min="263.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Issuers adjusted their operations in numerous ways to manage the impact of COVID-19 on their<inno:br/>operations and liquidity. Various measures/operational responses disclosed by issuers included:</inno:font></inno:block></inno:text><inno:text id="text-48" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="97.0" x-min="59.0" y-max="390.0" y-min="330.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Measures<inno:br/>Taken to<inno:br/>Reduce<inno:br/>COVID-19<inno:br/>Impact/<inno:br/>Operational<inno:br/>Responses</inno:font></inno:b></inno:block></inno:text><inno:text id="text-49" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="228.0" x-min="119.0" y-max="307.0" y-min="292.0"><inno:nec bbox="187.6 322.93 192.65 326.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Government assistance programs</inno:font></inno:color></inno:block></inno:text><inno:text id="text-50" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="226.0" x-min="119.0" y-max="313.0" y-min="307.1"><inno:nec bbox="187.6 309.43 192.65 313.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Change in product or service mix</inno:font></inno:color></inno:block></inno:text><inno:text id="text-51" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="300.0" x-min="118.0" y-max="323.9" y-min="315.0"><inno:nec bbox="187.6 295.93 192.65 299.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Reduction in discretionary expenses</inno:font></inno:color></inno:block></inno:text><inno:text id="text-52" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="304.0" x-min="118.0" y-max="330.9" y-min="324.0"><inno:nec bbox="187.6 282.43 192.65 286.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Change in budget or deferral of capital projects/acquisitions</inno:font></inno:color></inno:block></inno:text><inno:text id="text-53" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="236.0" x-min="119.0" y-max="341.0" y-min="331.0"><inno:nec bbox="187.6 268.93 192.65 272.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Decrease in salaries/director fees</inno:font></inno:color></inno:block></inno:text><inno:text id="text-54" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="186.0" x-min="119.0" y-max="350.0" y-min="342.0"><inno:nec bbox="187.6 255.43 192.65 259.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Employee layoffs</inno:font></inno:color></inno:block></inno:text><inno:text id="text-55" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="225.0" x-min="118.0" y-max="359.0" y-min="350.1"><inno:nec bbox="187.6 241.93 192.65 245.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Additional oversight measures</inno:font></inno:color></inno:block></inno:text><inno:text id="text-56" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="264.0" x-min="118.0" y-max="366.9" y-min="359.1"><inno:nec bbox="187.6 228.43 192.65 232.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Modification of payment terms with suppliers</inno:font></inno:color></inno:block></inno:text><inno:text id="text-57" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="232.0" x-min="119.0" y-max="376.0" y-min="367.0"><inno:nec bbox="187.6 214.93 192.65 218.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">New or amended credit agreements</inno:font></inno:color></inno:block></inno:text><inno:text id="text-58" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="237.0" x-min="118.0" y-max="389.0" y-min="376.1"><inno:nec bbox="187.6 201.43 192.65 205.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Change in dividends or distributions<inno:br/><inno:nec bbox="187.6 187.93 192.65 191.86" cid="1" code="0xf0b7" fid="21:0"/> A i thi d t fi i</inno:font></inno:color></inno:block></inno:text><inno:text id="text-59" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="259.0" x-min="117.0" y-max="402.0" y-min="389.1"><inno:nec bbox="187.6 187.93 192.65 191.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">ccess ng t r party nanc ng<inno:br/><inno:nec bbox="187.6 174.43 192.65 178.36" cid="1" code="0xf0b7" fid="21:0"/> Implementation of business continuity plans</inno:font></inno:color></inno:block></inno:text><inno:text id="text-60" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="238.0" x-min="119.0" y-max="410.9" y-min="403.0"><inno:nec bbox="187.6 160.93 192.65 164.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Suspension of issuer share buybacks</inno:font></inno:color></inno:block></inno:text><inno:text id="text-61" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="186.0" x-min="119.0" y-max="419.0" y-min="411.0"><inno:nec bbox="187.6 147.43 192.65 151.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Disposal of assets</inno:font></inno:color></inno:block></inno:text><inno:text id="text-62" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="351.0" x-min="42.0" y-max="470.0" y-min="437.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Most issuers reviewed were proactive in providing quality and detailed disclosures. For example, we<inno:br/>observed several issuers significantly expand their MD&amp;A to provide detailed operational updates<inno:br/>addressing the impact of COVID-19 as well as issuers providing additional disclosure addressing debt<inno:br/>covenants and related compliance. We also noted most issuers adequately disclosed impairments of non-</inno:font></inno:block></inno:text><inno:text id="text-63" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="202.0" x-min="193.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-6-</inno:font></inno:block></inno:text><inno:text id="text-64" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="349.0" x-min="43.0" y-max="62.0" y-min="41.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">financial assets due to a deterioration in their business since the onset of the pandemic. However, we<inno:br/>identified several areas where disclosure could be improved for many issuers including the following:</inno:font></inno:block></inno:text><inno:table id="table-1" type="table"><inno:block page="4" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="480.0" y-min="66.0"><inno:tr row="1">
<inno:td col="1" id="table-1-1-1" x-max="126.5" x-min="45.0" y-max="76.5" y-min="66.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Area of Disclosure</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-1-1-2" x-max="350.0" x-min="126.5" y-max="76.5" y-min="66.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Key Observations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-1-2-1" x-max="126.5" x-min="45.0" y-max="178.0" y-min="76.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">MD&amp;A</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-1-2-2" rowspan="2" x-max="350.0" x-min="126.5" y-max="274.05" y-min="76.5"><inno:nec bbox="219.3 662.04 224.81 666.32" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Discussion of measures taken to reduce COVID-19 impact</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">-<inno:br/>Many issuers provided “lists” of measures employed to manage<inno:br/>operational and liquidity risks but did not provide an adequate<inno:br/>discussion to address the anticipated impact to the issuer.</inno:font><inno:br/><inno:nec bbox="219.3 609.44 224.81 613.72" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Analysis of overall performance and operations</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Most issuers<inno:br/>that quantitatively disclosed variances related to COVID-19 (e.g.,<inno:br/>impact to sales) did not explain the methodology used by<inno:br/>management in determining that fluctuations were isolated to<inno:br/>COVID-19.<inno:br/><inno:nec bbox="219.3 544.14 224.81 548.42" cid="1" code="0xf0b7" fid="21:0"/> Several issuers provided limited disclosure of known trends or<inno:br/>events related to COVID-19 that are likely to affect future<inno:br/>performance.</inno:font><inno:br/><inno:nec bbox="219.3 504.14 224.81 508.42" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Liquidity and capital resources</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Many issuers with material<inno:br/>liquidity risks did not disclose in detail their ability to meet<inno:br/>working capital requirements, planned growth initiatives or to fund<inno:br/>developmental activities and capital expenditures. Lack of<inno:br/>disclosure regarding trends or expected fluctuations in liquidity<inno:br/>taking into account events or uncertainties related to COVID-19<inno:br/>was commonly observed.</inno:font><inno:br/><inno:nec bbox="219.3 413.54 224.81 417.82" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Risk factor disclosure</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Several issuers provided “lists” of risks<inno:br/>without discussion or general disclosures that touched on general<inno:br/>economic or societal impacts of COVID-19 and did not describe<inno:br/>entity-specific COVID-19-related risks.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-1-3-1" rowspan="2" x-max="126.5" x-min="45.0" y-max="480.0" y-min="178.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Financial Statements</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-1-4-1" x-max="350.0" x-min="126.5" y-max="480.0" y-min="274.05"><inno:nec bbox="219.3 361.23 224.35 365.16" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">General</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers failed to adequately update their<inno:br/>disclosures and assumptions impacted by COVID-19 in the context<inno:br/>of testing impairments of goodwill and intangible assets,<inno:br/>measuring fair value (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FV</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) and estimating expected credit losses.</inno:font><inno:br/><inno:nec bbox="219.3 309.83 224.35 313.76" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Significant judgements and measurement uncertainties</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">– Some<inno:br/>issuers failed to include entity-specific disclosure for significant<inno:br/>judgements or measurement uncertainties or only included this<inno:br/>disclosure in their MD&amp;A but not in their financial statements.</inno:font><inno:br/><inno:nec bbox="219.3 258.33 224.35 262.26" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Impairment of non-financial assets</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">– A few issuers did not<inno:br/>identify reasons for impairments or just noted “negative economic<inno:br/>impacts of COVID-19” as an impairment indicator for all cash<inno:br/>generating units (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">CGU</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">s) but did not elaborate on those impacts.</inno:font><inno:br/><inno:nec bbox="219.3 206.93 224.35 210.86" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Going concern</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers breached financial covenants<inno:br/>during the reporting period but did not disclose the implications of<inno:br/>breaches on the issuer's ability to continue as a going concern.<inno:br/>Some issuers disclosed “close call” situations but did not disclose<inno:br/>the mitigating actions that impacted their determination that there<inno:br/>were no material uncertainties that cast significant doubt on the<inno:br/>issuer’s ability to continue as a going concern (e.g. successful<inno:br/>negotiation of credit facilities subsequent to period end).</inno:font><inno:br/><inno:nec bbox="219.3 104.83 224.35 108.76" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Government assistance</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Over half of the issuers we reviewed<inno:br/>recognized, or disclosed in subsequent events, COVID-19 related<inno:br/>government assistance in their financial statements since the<inno:br/>outbreak of the COVID-19 pandemic. Some issuers did not<inno:br/>disclose the nature and extent of the government assistance or the</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-65" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="201.0" x-min="194.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-7-</inno:font></inno:block></inno:text><inno:table id="table-2" type="table"><inno:block page="5" page-height="512" page-width="396" x-max="352.0" x-min="45.0" y-max="342.0" y-min="42.0"><inno:tr row="1">
<inno:td col="1" id="table-2-1-1" x-max="137.0" x-min="45.0" y-max="54.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Area of Disclosure</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-1-2" x-max="352.0" x-min="137.0" y-max="54.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Key Observations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-2-2-1" x-max="137.0" x-min="45.0" y-max="152.0" y-min="54.5"/>
<inno:td col="2" id="table-2-2-2" x-max="352.0" x-min="137.0" y-max="152.0" y-min="54.5"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">accounting policy adopted including the methods of presentation.</inno:font><inno:br/><inno:nec bbox="219.3 688.23 224.35 692.16" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Expected credit losses (ECL)</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Only a few issuers disclosed the<inno:br/>use of COVID-19-induced adjustments/overlays to their ECL<inno:br/>models.</inno:font><inno:br/><inno:nec bbox="219.3 649.43 224.35 653.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Financial Instrument Risk Disclosure -</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Some issuers that<inno:br/>experienced material adverse impacts of COVID-19 did not<inno:br/>provide an entity-specific update to their risk disclosure in the<inno:br/>financial statements.</inno:font><inno:br/><inno:nec bbox="219.3 598.03 224.35 601.96" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">COVID-19 related amendments to IFRS 16</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="11.00pt"><inno:i>Leases</inno:i></inno:font> <inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">for Lessees<inno:br/>–</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Certain issuers did not sufficiently disclose whether they applied<inno:br/>the practical expedient to either all or some of their rent<inno:br/>concessions.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-2-3-1" x-max="137.0" x-min="45.0" y-max="209.5" y-min="152.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGMs</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-3-2" x-max="352.0" x-min="137.0" y-max="209.5" y-min="152.0"><inno:nec bbox="219.3 546.03 224.35 549.96" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGMs adjusted for COVID-19</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Most issuers did not present<inno:br/>NGMs that adjusted for the impact of COVID-19. However, our<inno:br/>review found isolated instances of potentially misleading NGMs in<inno:br/>relation to COVID-19 (e.g., adjusting for expenses attributable to<inno:br/>COVID-19 without adjusting for government subsidies or<inno:br/>“normalizing” revenue or expenses for the year-to-date period<inno:br/>based on more positive results for one quarter).</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-2-4-1" x-max="137.0" x-min="45.0" y-max="252.05" y-min="209.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-4-2" x-max="352.0" x-min="137.0" y-max="252.05" y-min="209.5"><inno:nec bbox="219.3 456.83 223.89 460.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI related to COVID-19</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- In certain cases, we observed<inno:br/>insufficient disclosure of assumptions used to develop FLI and<inno:br/>failure to adequately update the MD&amp;A for events and risks that<inno:br/>could cause actual results for future periods to differ materially<inno:br/>from previously disclosed FLI.</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-2-5-1" x-max="137.0" x-min="45.0" y-max="301.5" y-min="252.05"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Material Change Reporting</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-5-2" x-max="352.0" x-min="137.0" y-max="301.5" y-min="252.05"><inno:nec bbox="219.3 392.43 224.35 396.36" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">If COVID-19 has an equal effect throughout an issuer’s industry, a<inno:br/>material change report may not be required. Only a few issuers<inno:br/>reviewed filed material change reports in relation to COVID-19<inno:br/>although in some instances changes to the issuer’s business, operations<inno:br/>or capital were more unique or more significant to them than to others<inno:br/>in their industry.</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-2-6-1" x-max="137.0" x-min="45.0" y-max="342.0" y-min="301.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Promotional Disclosures</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-6-2" x-max="352.0" x-min="137.0" y-max="342.0" y-min="301.5"><inno:nec bbox="219.3 315.13 224.35 319.06" cid="1" code="0xf0b7" fid="21:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Potentially misleading disclosures</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers concentrated in<inno:br/>the biotech/pharma industry provided disclosure in relation to<inno:br/>COVID-19 that was overly promotional and/or lacked specificity<inno:br/>to fully address the issuer’s business intentions and expected<inno:br/>milestones.</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-66" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="411.0" y-min="349.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Please refer to</inno:font> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Appendix A – Key Observations and Disclosure Considerations –</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">for more detail<inno:br/>regarding the significant issues identified in our reviews and disclosure guidance. Please refer to</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Appendix B – Disclosure Examples</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">where we have included some examples of deficient disclosure<inno:br/>contrasted against improved entity-specific disclosure. The observations and disclosure considerations<inno:br/>presented do not represent an exhaustive list and do not represent all the requirements that could apply to<inno:br/>a particular issuer’s situation. Issuers should consider their specific business and operations and provide<inno:br/>clear and transparent disclosure of the impact of COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-67" type="text"><inno:block page="6" page-height="512" page-width="396" x-max="201.0" x-min="194.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-8-</inno:font></inno:block></inno:text><inno:text id="text-68" type="text"><inno:block page="6" page-height="512" page-width="396" x-max="326.0" x-min="46.0" y-max="56.0" y-min="42.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Appendix A – Key Observations and Disclosure Considerations</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-69" type="text"><inno:block page="6" page-height="512" page-width="396" x-max="133.0" x-min="43.0" y-max="74.0" y-min="62.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="14.00pt">A.1 MD&amp;A Reporting</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-70" type="text"><inno:block page="6" page-height="512" page-width="396" x-max="350.0" x-min="43.0" y-max="117.0" y-min="79.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">MD&amp;A is the cornerstone of a reporting issuer’s overall financial disclosure and should provide an<inno:br/>analytical and balanced discussion of the issuer’s results of operations and financial condition through the<inno:br/>eyes of management. MD&amp;A disclosure should be specific, useful and understandable. The MD&amp;A<inno:br/>requirements are set out in Form 51-102F1</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Management’s Discussion and Analysis</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Form 51-102F1</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">).</inno:font></inno:block></inno:text><inno:text id="text-71" type="text"><inno:block page="6" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="157.0" y-min="120.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Some of the observations and considerations below may be relevant for issuers that prepare an annual<inno:br/>information form (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">AIF</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) with reference to Form 51-102F2</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Annual Information Form</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Form 51-102F2</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">).<inno:br/>Specifically, issuers should consider additional disclosure for COVID-19 under Item 4-</inno:font><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>General<inno:br/>Development of the Business</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">and Item 5-</inno:font><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Describe the Business</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">of Form 51-102F2.</inno:font></inno:block></inno:text><inno:table id="table-3" type="table"><inno:block page="6" page-height="512" page-width="396" x-max="366.0" x-min="45.0" y-max="475.0" y-min="161.0"><inno:tr row="1">
<inno:td col="1" id="table-3-1-1" x-max="106.0" x-min="45.0" y-max="171.0" y-min="161.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-3-1-2" x-max="220.05" x-min="106.0" y-max="171.0" y-min="161.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-3-1-3" x-max="366.0" x-min="220.05" y-max="171.0" y-min="161.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-3-2-1" x-max="106.0" x-min="45.0" y-max="296.05" y-min="171.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">General: Discussion<inno:br/>of Operational<inno:br/>Status</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-3-2-2" rowspan="2" x-max="220.05" x-min="106.0" y-max="466.95" y-min="171.0"><inno:nec bbox="176.7 508.03 181.29 511.6" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers provided detailed<inno:br/>operational updates in press<inno:br/>releases but included limited<inno:br/>disclosure in MD&amp;A filings.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</inno:font></inno:b><inno:br/><inno:nec bbox="176.7 438.03 181.29 441.6" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Many affected issuers significantly<inno:br/>expanded their MD&amp;A to explain<inno:br/>the impact of COVID-19 to the<inno:br/>issuer’s industry, operations,<inno:br/>customers, suppliers etc. Several<inno:br/>issuers disclosed industry and<inno:br/>relevant operational information to<inno:br/>help users frame and understand<inno:br/>the effects on the issuer’s financial<inno:br/>results.</inno:font></inno:td>
<inno:td col="3" id="table-3-2-3" x-max="366.0" x-min="220.05" y-max="296.05" y-min="171.0"><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provide a detailed and transparent discussion<inno:br/>on how COVID-19 has altered the issuer’s<inno:br/>industry and day to day operations. Insight<inno:br/>should be provided into the issuer’s current<inno:br/>operating status and the operational challenges<inno:br/>that management is monitoring. This will vary<inno:br/>materially by issuer and by industry.<inno:br/><inno:nec bbox="346.9 432.53 351.49 436.1" cid="1" code="0xf0b7" fid="21:0"/> MD&amp;A is a standalone document. Material<inno:br/>operational updates should be reflected in<inno:br/>MD&amp;A filings to provide additional context for<inno:br/>analyzing financial results. Having a separate<inno:br/>“COVID-19” section in the MD&amp;A preceding<inno:br/>the discussion of financial results may provide<inno:br/>a useful framework in understanding the<inno:br/>issuer’s analysis of financial performance,<inno:br/>financial condition and liquidity.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-3-3-1" x-max="106.0" x-min="45.0" y-max="466.95" y-min="296.05"/>
<inno:td col="2" id="table-3-3-2" x-max="366.0" x-min="220.05" y-max="466.95" y-min="296.05"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider:</inno:font></inno:b><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Impact of health and safety guidelines on<inno:br/>operations and on how the issuer conducts its<inno:br/>business</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">How the current environment has altered<inno:br/>demand or ability to provide products and<inno:br/>services (both adversely and positively)</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Details of operational closures and restrictions</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Providing information to understand the impact<inno:br/>of shutdowns and closures</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Disclosing relevant industry data that assists<inno:br/>with understanding restrictions and other<inno:br/>impacts to the issuer’s business</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Discussing how customers and suppliers have<inno:br/>been impacted and the effect on the issuer</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Providing a discussion for each segment or<inno:br/>geographic location to the extent operations are<inno:br/>impacted differently</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Explaining how industry and economic factors<inno:br/>have uniquely impacted the issuer</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-3-4-1" x-max="106.0" x-min="45.0" y-max="475.0" y-min="466.95"/>
<inno:td col="2" id="table-3-4-2" x-max="220.05" x-min="106.0" y-max="475.0" y-min="466.95"/>
<inno:td col="3" id="table-3-4-3" x-max="366.0" x-min="220.05" y-max="475.0" y-min="466.95"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Part 1, Item 1.2, Item 1.4 of Form 51-</inno:font></inno:b></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-72" type="text"><inno:block page="7" page-height="512" page-width="396" x-max="201.0" x-min="193.0" y-max="31.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-9-</inno:font></inno:block></inno:text><inno:table id="table-4" type="table"><inno:block page="7" page-height="512" page-width="396" x-max="363.0" x-min="45.0" y-max="479.0" y-min="42.0"><inno:tr row="1">
<inno:td col="1" id="table-4-1-1" x-max="109.5" x-min="45.0" y-max="65.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-4-1-2" x-max="219.5" x-min="109.5" y-max="65.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-4-1-3" x-max="255.5" x-min="219.5" y-max="65.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">102F1</inno:font></inno:b></inno:td>
<inno:td col="4" colspan="3" id="table-4-1-4" x-max="363.0" x-min="255.5" y-max="65.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-4-2-1" rowspan="2" x-max="109.5" x-min="45.0" y-max="204.95" y-min="65.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">General: Discussion<inno:br/>of Operational<inno:br/>Responses</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-4-2-2" rowspan="3" x-max="219.5" x-min="109.5" y-max="219.05" y-min="65.5"><inno:nec bbox="176.7 680.43 181.29 684.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The majority of issuers included<inno:br/>qualitative disclosure of the<inno:br/>measures taken in response to<inno:br/>COVID-19. However, some<inno:br/>issuers only listed measures taken<inno:br/>without providing sufficient detail<inno:br/>to understand the impact to the<inno:br/>issuer.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</inno:font></inno:b><inno:br/><inno:nec bbox="176.7 563.83 181.29 567.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Discussion of the measures taken,<inno:br/>the current and expected impact to<inno:br/>revenue or expenses and the<inno:br/>anticipated time period such<inno:br/>measures will remain in effect.</inno:font></inno:td>
<inno:td col="3" colspan="2" id="table-4-2-3" x-max="273.95" x-min="219.5" y-max="78.0" y-min="65.5"><inno:nec bbox="346.9 674.43 351.49 678.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">It is important</inno:font></inno:td>
<inno:td col="4" id="table-4-2-4" x-max="311.0" x-min="273.95" y-max="78.0" y-min="65.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">for investors t</inno:font></inno:td>
<inno:td col="5" id="table-4-2-5" x-max="363.0" x-min="311.0" y-max="78.0" y-min="65.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">to understand</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" colspan="4" id="table-4-3-1" x-max="363.0" x-min="219.5" y-max="204.95" y-min="78.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">operational measures taken in response to<inno:br/>COVID-19 that have had a material impact on<inno:br/>operations and that may reasonably affect<inno:br/>future performance. This includes disclosing in<inno:br/>sufficient detail cost saving measures,<inno:br/>restructuring initiatives or realignments of<inno:br/>operational and financial resources in response<inno:br/>to COVID-19.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider:</inno:font></inno:b><inno:br/><inno:nec bbox="346.9 546.73 351.49 550.3" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Discuss the impact of operational measures<inno:br/>taken that may increase costs (e.g., salary<inno:br/>premiums)<inno:br/><inno:nec bbox="346.9 511.33 351.49 514.9" cid="1" code="0xf0b7" fid="21:0"/> Describe how operational responses change as<inno:br/>conditions evolve</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-4-4-1" x-max="109.5" x-min="45.0" y-max="219.05" y-min="204.95"/>
<inno:td col="2" colspan="4" id="table-4-4-2" x-max="363.0" x-min="219.5" y-max="219.05" y-min="204.95"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Part 1, Item 1.2, Item 1.4 of Form 51-<inno:br/>102F1</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-4-5-1" x-max="109.5" x-min="45.0" y-max="479.0" y-min="219.05"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Analysis of Overall<inno:br/>Performance and<inno:br/>Operations</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-4-5-2" x-max="219.5" x-min="109.5" y-max="479.0" y-min="219.05"><inno:nec bbox="176.7 440.13 181.29 443.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Approximately 20% of issuers<inno:br/>disclosed COVID-19 as the reason<inno:br/>for period over period variances<inno:br/>without analyzing entity-specific<inno:br/>factors.<inno:br/><inno:nec bbox="176.7 370.13 181.29 373.7" cid="1" code="0xf0b7" fid="21:0"/> It was unclear for some issuers<inno:br/>how certain costs, in particular<inno:br/>restructuring costs, were fully<inno:br/>attributable to COVID-19 when<inno:br/>the issuer had pre-existing<inno:br/>operational issues.<inno:br/><inno:nec bbox="176.7 288.63 181.29 292.2" cid="1" code="0xf0b7" fid="21:0"/> Most issuers that quantitatively<inno:br/>disclosed variances related to<inno:br/>COVID-19 (e.g., impact to sales)<inno:br/>did not explain the methodology<inno:br/>used by management in<inno:br/>determining that fluctuations were<inno:br/>isolated to COVID-19.<inno:br/><inno:nec bbox="176.7 195.53 181.29 199.1" cid="1" code="0xf0b7" fid="21:0"/> Some issuers did not disclose the<inno:br/>impacts that government assistance<inno:br/>attributable to COVID-19 had on<inno:br/>their performance, operations and<inno:br/>cash flows.</inno:font></inno:td>
<inno:td col="3" colspan="4" id="table-4-5-3" x-max="363.0" x-min="219.5" y-max="479.0" y-min="219.05"><inno:nec bbox="346.7 440.13 351.29 443.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Avoid simply making statements attributing<inno:br/>negative results to COVID-19. Instead,<inno:br/>provide a meaningful discussion on the<inno:br/>material impacts (both positive and negative)<inno:br/>of COVID-19 on the issuer’s operations.<inno:br/>Disclose issuer-specific impacts on both<inno:br/>revenues and expenses and provide disclosure<inno:br/>by segment.<inno:br/><inno:nec bbox="346.9 347.03 351.49 350.6" cid="1" code="0xf0b7" fid="21:0"/> Issuers must have a basis for attributing costs<inno:br/>to COVID-19, especially when certain<inno:br/>conditions existed prior to COVID-19. Other<inno:br/>reasons for material fluctuations not related to<inno:br/>COVID-19 should be disclosed with equal<inno:br/>prominence.<inno:br/><inno:nec bbox="346.9 277.03 351.49 280.6" cid="1" code="0xf0b7" fid="21:0"/> Quantification of material factors, where<inno:br/>practicable, can provide an understanding of an<inno:br/>issuer’s performance. However, it may be<inno:br/>difficult for an issuer to determine with<inno:br/>accuracy the quantitative impact of COVID-19.<inno:br/>In order to avoid misleading investors, issuers<inno:br/>should explain the methodology used in their<inno:br/>calculation and provide information about the<inno:br/>judgements and estimations made by<inno:br/>management when quantifying impacts.<inno:br/><inno:nec bbox="346.9 160.83 351.49 164.4" cid="1" code="0xf0b7" fid="21:0"/> An understanding of the amounts of government<inno:br/>assistance received and where such funding is<inno:br/>recorded in the financial statements may be<inno:br/>necessary to understand historical results and<inno:br/>future trends, when material. Issuers are reminded<inno:br/>to provide balanced disclosure of both the positive<inno:br/>and adverse impacts to operations, financial<inno:br/>condition and cash flows. Also see “</inno:font><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="10.00pt"><inno:i>Appendix<inno:br/>A.2– Key Observations and Considerations on<inno:br/>Financial Statements.</inno:i></inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">”</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-73" type="text"><inno:block page="8" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="31.0" y-min="23.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-10-</inno:font></inno:block></inno:text><inno:table id="table-5" type="table"><inno:block page="8" page-height="512" page-width="396" x-max="362.0" x-min="45.0" y-max="481.0" y-min="41.0"><inno:tr row="1">
<inno:td col="1" id="table-5-1-1" x-max="108.0" x-min="45.0" y-max="99.95" y-min="41.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-5-1-2" x-max="220.5" x-min="108.0" y-max="99.95" y-min="41.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Industry observations:</inno:font></inno:b><inno:br/><inno:nec bbox="176.7 661.34 182.21 665.62" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">We observed additional<inno:br/>disclosures to assist in<inno:br/>understanding COVID-19 impacts.</inno:font></inno:td>
<inno:td col="3" id="table-5-1-3" rowspan="3" x-max="362.0" x-min="220.5" y-max="247.95" y-min="41.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider:</inno:font></inno:b><inno:br/><inno:nec bbox="349.2 663.13 353.79 666.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">How decreases or increases in demand for<inno:br/>products and services impacted financial results<inno:br/><inno:nec bbox="349.2 639.33 353.79 642.9" cid="1" code="0xf0b7" fid="21:0"/> Impact of operational closures<inno:br/><inno:nec bbox="349.2 627.03 353.79 630.6" cid="1" code="0xf0b7" fid="21:0"/> How costs, including changes in prices, influenced<inno:br/>results<inno:br/><inno:nec bbox="349.2 603.23 353.79 606.8" cid="1" code="0xf0b7" fid="21:0"/> Effect of altered terms with customers / lessees /<inno:br/>borrowers<inno:br/><inno:nec bbox="349.2 579.43 353.79 583.0" cid="1" code="0xf0b7" fid="21:0"/> Impact on customers’ supply chains or distribution<inno:br/>channels<inno:br/><inno:nec bbox="349.2 555.63 353.79 559.2" cid="1" code="0xf0b7" fid="21:0"/> Changes to planned projects and development<inno:br/>activities<inno:br/><inno:nec bbox="349.2 531.83 353.79 535.4" cid="1" code="0xf0b7" fid="21:0"/> Impact of government support<inno:br/><inno:nec bbox="349.2 519.63 353.79 523.2" cid="1" code="0xf0b7" fid="21:0"/> Reasons for fair value changes/impairment<inno:br/>charges/credit losses<inno:br/><inno:nec bbox="349.2 495.83 353.79 499.4" cid="1" code="0xf0b7" fid="21:0"/> Details of restructuring plans and related costs<inno:br/><inno:nec bbox="349.2 483.53 353.79 487.1" cid="1" code="0xf0b7" fid="21:0"/> Material variations in other expenses related to<inno:br/>COVID-19<inno:br/><inno:nec bbox="349.2 459.73 353.79 463.3" cid="1" code="0xf0b7" fid="21:0"/> A discussion of any breaches of material contracts<inno:br/><inno:nec bbox="349.2 447.53 353.79 451.1" cid="1" code="0xf0b7" fid="21:0"/> Explaining any changes in use of proceeds from<inno:br/>financing as compared to prior disclosures and the<inno:br/>impact on the issuer’s ability to achieve business<inno:br/>objectives/milestones</inno:font></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-5-2-1" x-max="108.0" x-min="45.0" y-max="111.05" y-min="99.95"/>
<inno:td col="2" id="table-5-2-2" x-max="220.5" x-min="108.0" y-max="111.05" y-min="99.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">.<inno:br/>For example:</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-5-3-1" x-max="108.0" x-min="45.0" y-max="247.95" y-min="111.05"/>
<inno:td col="2" id="table-5-3-2" x-max="220.5" x-min="108.0" y-max="247.95" y-min="111.05"><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Retail/service industry</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">–<inno:br/>details of store closures, # of<inno:br/>weeks operating, ecommerce<inno:br/>sales vs in store sales</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Real estate industry</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">- an<inno:br/>analysis of space leased by<inno:br/>customers that were<inno:br/>negatively<inno:br/>affected/unaffected/<inno:br/>positively affected by the<inno:br/>pandemic and the proportion<inno:br/>of tenants that have applied<inno:br/>for government assistance</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-5-4-1" x-max="108.0" x-min="45.0" y-max="404.5" y-min="247.95"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Known Trends and<inno:br/>Events that are<inno:br/>Reasonably Likely<inno:br/>to Affect Future<inno:br/>Performance</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-5-4-2" rowspan="2" x-max="220.5" x-min="108.0" y-max="424.0" y-min="247.95"><inno:nec bbox="176.7 370.73 181.29 374.3" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Approximately one third of issuers<inno:br/>provided boilerplate disclosure in<inno:br/>this area. Some issuers cited the<inno:br/>degree of uncertainty related to<inno:br/>COVID-19 making it too difficult<inno:br/>to predict the overall impact of<inno:br/>COVID-19 on the issuer’s future<inno:br/>performance.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</inno:font></inno:b><inno:br/><inno:nec bbox="176.7 254.53 181.29 258.1" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">“Outlook” sections discussing the<inno:br/>anticipated medium to longer term<inno:br/>impact of a continuing pandemic<inno:br/>to the issuer’s business and<inno:br/>industry.<inno:br/><inno:nec bbox="176.7 196.13 181.29 199.7" cid="1" code="0xf0b7" fid="21:0"/> Disclosure of how operations may<inno:br/>be impacted post-COVID-19 due<inno:br/>to anticipated economic impacts or<inno:br/>anticipated changes in consumer<inno:br/>behaviour.</inno:font></inno:td>
<inno:td col="3" id="table-5-4-3" x-max="362.0" x-min="220.5" y-max="404.5" y-min="247.95"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Item 1.2, Item 1.4 of Form 51-102F1</inno:font></inno:b><inno:br/><inno:nec bbox="346.9 370.73 351.49 374.3" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">In times of uncertainty, there may be less<inno:br/>investor focus on historical information and<inno:br/>more focus on known trends, and uncertainties<inno:br/>that are likely to impact future performance. As<inno:br/>the COVID-19 pandemic evolves, insightful<inno:br/>disclosure how COVID-19 may impact future<inno:br/>operations will be important to investors.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider:</inno:font></inno:b><inno:br/><inno:nec bbox="346.9 266.13 351.49 269.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">How future periods may be impacted differently<inno:br/>in comparison to the current period<inno:br/><inno:nec bbox="346.9 242.33 351.49 245.9" cid="1" code="0xf0b7" fid="21:0"/> Impacts to the issuer’s business or industry that<inno:br/>may continue post COVID-19<inno:br/><inno:nec bbox="346.9 218.53 351.49 222.1" cid="1" code="0xf0b7" fid="21:0"/> Whether the issuer anticipates material<inno:br/>restructuring charges going forward<inno:br/><inno:nec bbox="346.9 194.73 351.49 198.3" cid="1" code="0xf0b7" fid="21:0"/> Future operating plans as issuers plan for recovery<inno:br/>from the COVID-19 pandemic</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-5-5-1" x-max="108.0" x-min="45.0" y-max="424.0" y-min="404.5"/>
<inno:td col="2" id="table-5-5-2" x-max="362.0" x-min="220.5" y-max="424.0" y-min="404.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Also see “Appendix A.3 –</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="10.00pt"><inno:i>Key Observations and<inno:br/>Considerations on Other Regulatory Matters - FLI</inno:i></inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">”</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-5-6-1" x-max="108.0" x-min="45.0" y-max="432.5" y-min="424.0"/>
<inno:td col="2" id="table-5-6-2" x-max="220.5" x-min="108.0" y-max="432.5" y-min="424.0"/>
<inno:td col="3" id="table-5-6-3" x-max="362.0" x-min="220.5" y-max="432.5" y-min="424.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Item 1.2, Item 1.4 of Form 51-102F1</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="7">
<inno:td col="1" id="table-5-7-1" x-max="108.0" x-min="45.0" y-max="481.0" y-min="432.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Liquidity and<inno:br/>Capital Resources</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-5-7-2" x-max="220.5" x-min="108.0" y-max="481.0" y-min="432.5"><inno:nec bbox="176.7 111.93 181.29 115.5" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The majority of issuers reviewed<inno:br/>had indicators of liquidity risk.<inno:br/>However, approximately 25% of<inno:br/>issuers did not adequately disclose<inno:br/>their ability to meet working<inno:br/>capital requirements or planned</inno:font></inno:td>
<inno:td col="3" id="table-5-7-3" x-max="362.0" x-min="220.5" y-max="481.0" y-min="432.5"><inno:nec bbox="346.9 111.93 351.49 115.5" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">COVID-19 has had a significant impact on the<inno:br/>liquidity and capital resources of many issuers<inno:br/>creating unique challenges and the need for new<inno:br/>financing resources. It is important for issuers<inno:br/>to provide a comprehensive discussion of their<inno:br/>initiatives to manage current and expected</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-74" type="text"><inno:block page="9" page-height="512" page-width="396" x-max="202.0" x-min="193.0" y-max="31.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-11</inno:font></inno:block></inno:text><inno:table id="table-6" type="table"><inno:block page="9" page-height="512" page-width="396" x-max="363.0" x-min="45.0" y-max="474.0" y-min="43.0"><inno:tr row="1">
<inno:td col="1" id="table-6-1-1" x-max="100.5" x-min="45.0" y-max="59.5" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-6-1-2" x-max="220.0" x-min="100.5" y-max="59.5" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b><inno:br/><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">rowth initiatives or to fund</inno:font></inno:td>
<inno:td col="3" id="table-6-1-3" rowspan="3" x-max="363.0" x-min="220.0" y-max="474.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b><inno:br/><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">liquidity and funding risks.<inno:br/><inno:nec bbox="346.9 686.23 351.49 689.8" cid="1" code="0xf0b7" fid="21:0"/> Issuers that have material liquidity risks might<inno:br/>consider disclosing: their most current working<inno:br/>capital amount, significant obligations that are<inno:br/>maturing in the short term, their cash burn rate<inno:br/>on a monthly or quarterly basis, the period of<inno:br/>time that they expect to be able to fund<inno:br/>operations and how they intend to prioritize<inno:br/>expenditures in the short term.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should:</inno:font></inno:b><inno:br/><inno:nec bbox="344.7 564.03 349.29 567.6" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provide a clear picture of the issuers working<inno:br/>capital, working capital needs and how those<inno:br/>needs relate to business plans and milestones<inno:br/><inno:nec bbox="344.7 528.63 349.29 532.2" cid="1" code="0xf0b7" fid="21:0"/> Detail liquidity risks including risk of default or<inno:br/>arrears on distributions, lease and debt<inno:br/>payments<inno:br/><inno:nec bbox="344.7 493.33 349.29 496.9" cid="1" code="0xf0b7" fid="21:0"/> Discuss the impact of altered payment terms<inno:br/>with customers and lessees<inno:br/><inno:nec bbox="344.7 469.53 349.29 473.1" cid="1" code="0xf0b7" fid="21:0"/> Discuss whether the issuer’s cost or access to<inno:br/>capital has changed<inno:br/><inno:nec bbox="344.7 445.73 349.29 449.3" cid="1" code="0xf0b7" fid="21:0"/> Quantify the impact of remedies where possible<inno:br/><inno:nec bbox="344.7 433.43 349.29 437.0" cid="1" code="0xf0b7" fid="21:0"/> Discuss how financing sources (e.g.,<inno:br/>public/private offerings, unused lines of credit)<inno:br/>meet the issuers immediate and longer-term<inno:br/>liquidity needs<inno:br/><inno:nec bbox="344.7 386.53 349.29 390.1" cid="1" code="0xf0b7" fid="21:0"/> Discuss how long other remedies to address<inno:br/>liquidity concerns are anticipated to be in effect<inno:br/>and the risks to the issuer when remedies expire<inno:br/><inno:nec bbox="344.7 351.23 349.29 354.8" cid="1" code="0xf0b7" fid="21:0"/> Consider what additional information<inno:br/>management is monitoring in relation to<inno:br/>liquidity that may be useful information to<inno:br/>investors<inno:br/><inno:nec bbox="344.7 304.33 349.29 307.9" cid="1" code="0xf0b7" fid="21:0"/> Discuss known trends or events that may<inno:br/>impact future liquidity and capital resources<inno:br/>(e.g., what events or uncertainties may impact<inno:br/>ability to service debt, meet other financial<inno:br/>obligations or access financing?)<inno:br/><inno:nec bbox="344.7 245.83 349.29 249.4" cid="1" code="0xf0b7" fid="21:0"/> Update material factors impacting liquidity and<inno:br/>capital resources up to the date of the MD&amp;A</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Item1.6 and Item 1.7 of Form 51-<inno:br/>102F1</inno:font></inno:b><inno:br/><inno:nec bbox="344.7 180.63 349.29 184.2" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">We encourage issuers with debt covenants to<inno:br/>discuss the terms and conditions of the debt<inno:br/>covenants, especially when a breach of the<inno:br/>covenant could trigger a material funding<inno:br/>requirement or early repayment.<inno:br/><inno:nec bbox="344.7 122.23 349.29 125.8" cid="1" code="0xf0b7" fid="21:0"/> If an issuer is close to breaching covenants or at<inno:br/>risk of default in future periods, this is material<inno:br/>information to be disclosed.<inno:br/><inno:nec bbox="344.6 86.83 349.19 90.4" cid="1" code="0xf0b7" fid="21:0"/> Discuss any additional requirements in<inno:br/>agreements with lenders that may restrict the<inno:br/>issuer’s business or access to other financing.</inno:font></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-6-2-1" x-max="100.5" x-min="45.0" y-max="328.0" y-min="59.5"/>
<inno:td col="2" id="table-6-2-2" x-max="220.0" x-min="100.5" y-max="328.0" y-min="59.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">growt n t at ves, or to un<inno:br/>developmental activities and<inno:br/>capital expenditures.<inno:br/><inno:nec bbox="176.7 663.13 181.29 666.7" cid="1" code="0xf0b7" fid="21:0"/> A common deficiency was the lack<inno:br/>of disclosure regarding trends or<inno:br/>expected fluctuations in an issuer’s<inno:br/>liquidity and capital resources,<inno:br/>taking into account events or<inno:br/>uncertainties related to COVID-19.<inno:br/><inno:nec bbox="176.7 593.13 181.29 596.7" cid="1" code="0xf0b7" fid="21:0"/> Many issuers discussed a wide<inno:br/>range of remedies to address<inno:br/>liquidity uncertainties. However,<inno:br/>some issuers did not quantify the<inno:br/>impact or discuss how long certain<inno:br/>remedies will remain in effect.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Industry Observations</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">:<inno:br/><inno:nec bbox="176.7 500.03 181.29 503.6" cid="1" code="0xf0b7" fid="21:0"/> We observed additional disclosure<inno:br/>regarding customers/tenants to<inno:br/>help understand the issuer’s<inno:br/>liquidity risk and future trends.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">For example:</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">some real estate<inno:br/>issuers disclosed % of tenants<inno:br/>undergoing restructuring, cash<inno:br/>rents received during the period<inno:br/>and categorized their tenant base<inno:br/>based on management’s<inno:br/>assessment of risk.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-6-3-1" x-max="100.5" x-min="45.0" y-max="474.0" y-min="328.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Debt Covenants</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-6-3-2" x-max="220.0" x-min="100.5" y-max="474.0" y-min="328.0"><inno:nec bbox="176.7 180.63 181.29 184.2" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">While issuers generally disclosed<inno:br/>compliance with debt covenants,<inno:br/>disclosure varied in relation to<inno:br/>providing the details of covenants<inno:br/>applicable to the issuer.<inno:br/><inno:nec bbox="176.7 122.23 181.29 125.8" cid="1" code="0xf0b7" fid="21:0"/> Many issuers disclosed<inno:br/>amendments to credit agreements<inno:br/>including changes to covenants,<inno:br/>covenant forgiveness for certain<inno:br/>periods and additional restrictions<inno:br/>placed on the issuer.</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-75" type="text"><inno:block page="10" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="31.0" y-min="23.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-12-</inno:font></inno:block></inno:text><inno:table id="table-7" type="table"><inno:block page="10" page-height="512" page-width="396" x-max="362.0" x-min="44.0" y-max="474.0" y-min="44.0"><inno:tr row="1">
<inno:td col="1" id="table-7-1-1" x-max="100.5" x-min="44.0" y-max="61.0" y-min="44.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-7-1-2" x-max="221.0" x-min="100.5" y-max="61.0" y-min="44.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-7-1-3" x-max="362.0" x-min="221.0" y-max="61.0" y-min="44.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-7-2-1" x-max="100.5" x-min="44.0" y-max="99.0" y-min="61.0"/>
<inno:td col="2" id="table-7-2-2" rowspan="2" x-max="221.0" x-min="100.5" y-max="125.0" y-min="61.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</inno:font></inno:b><inno:br/><inno:nec bbox="176.7 663.13 181.29 666.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Additional disclosure to facilitate<inno:br/>understanding of debt covenants<inno:br/>including quantitative disclosure of<inno:br/>covenant terms and related<inno:br/>compliance.</inno:font></inno:td>
<inno:td col="3" id="table-7-2-3" x-max="362.0" x-min="221.0" y-max="99.0" y-min="61.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Other considerations:</inno:font></inno:b><inno:br/><inno:nec bbox="346.9 663.13 351.49 666.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Amended credit agreements may be a material<inno:br/>contract.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-7-3-1" x-max="100.5" x-min="44.0" y-max="125.0" y-min="99.0"/>
<inno:td col="2" id="table-7-3-2" x-max="362.0" x-min="221.0" y-max="125.0" y-min="99.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Item 1.6 of Form 51-102F1, Item 12.2<inno:br/>of NI 51-102</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-7-4-1" x-max="100.5" x-min="44.0" y-max="474.0" y-min="125.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Risk Factor<inno:br/>Disclosure</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-7-4-2" x-max="221.0" x-min="100.5" y-max="474.0" y-min="125.0"><inno:nec bbox="176.7 580.33 181.29 583.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Most issuers updated their risk<inno:br/>factors in their MD&amp;A from<inno:br/>disclosure provided in annual<inno:br/>filings to include COVID-19<inno:br/>related disclosure.<inno:br/><inno:nec bbox="176.7 521.93 181.29 525.5" cid="1" code="0xf0b7" fid="21:0"/> Over 30% of issuers provided<inno:br/>“lists” of risks or disclosures that<inno:br/>only touched on general economic<inno:br/>or societal impacts of COVID-19<inno:br/>and did not describe entity-specific<inno:br/>COVID-19-related risks.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</inno:font></inno:b><inno:br/><inno:nec bbox="176.7 428.83 181.29 432.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers provided useful<inno:br/>disclosure by distinguishing<inno:br/>between short term risks and<inno:br/>anticipated longer term risks<inno:br/>related to the pandemic.</inno:font></inno:td>
<inno:td col="3" id="table-7-4-3" x-max="362.0" x-min="221.0" y-max="474.0" y-min="125.0"><inno:nec bbox="346.9 580.33 351.49 583.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provide entity specific risk factor disclosure<inno:br/>related to COVID-19 in enough detail to<inno:br/>understand the current and potential impact of<inno:br/>COVID-19 on the issuer’s business.<inno:br/><inno:nec bbox="346.9 533.43 351.49 537.0" cid="1" code="0xf0b7" fid="21:0"/> Disclosure of risks in the order of seriousness from<inno:br/>the most serious to least serious helps investors<inno:br/>understand how management views the<inno:br/>importance of such risks. (Note that this is a<inno:br/>requirement for disclosure of risks in an issuer’s<inno:br/>AIF).</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider the impacts of:</inno:font></inno:b><inno:br/><inno:nec bbox="346.9 434.33 351.49 437.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Disruptions to day-day operations resulting from<inno:br/>health and safety measures and government-<inno:br/>imposed closures<inno:br/><inno:nec bbox="346.9 399.03 351.49 402.6" cid="1" code="0xf0b7" fid="21:0"/> Human resource/staff constraints<inno:br/><inno:nec bbox="346.9 386.73 351.49 390.3" cid="1" code="0xf0b7" fid="21:0"/> Cybersecurity or information technology risks that<inno:br/>may be heightened with the pandemic<inno:br/><inno:nec bbox="346.9 362.93 351.49 366.5" cid="1" code="0xf0b7" fid="21:0"/> Ability to sustain changes in<inno:br/>revenues/expenses/negative cash flow from<inno:br/>operations<inno:br/><inno:nec bbox="346.9 327.63 351.49 331.2" cid="1" code="0xf0b7" fid="21:0"/> Changes in consumer demand<inno:br/><inno:nec bbox="346.9 315.33 351.49 318.9" cid="1" code="0xf0b7" fid="21:0"/> Ability to access government funding<inno:br/><inno:nec bbox="346.9 303.13 351.49 306.7" cid="1" code="0xf0b7" fid="21:0"/> Requirements under lending agreements<inno:br/><inno:nec bbox="346.9 290.83 351.49 294.4" cid="1" code="0xf0b7" fid="21:0"/> Changes in commodity prices<inno:br/><inno:nec bbox="346.9 278.63 351.49 282.2" cid="1" code="0xf0b7" fid="21:0"/> Volatility in the capital markets and access to<inno:br/>financing and capital on reasonable terms<inno:br/><inno:nec bbox="346.9 254.83 351.49 258.4" cid="1" code="0xf0b7" fid="21:0"/> Limitations on the ability of issuers’ customers to<inno:br/>perform and make timely payments<inno:br/><inno:nec bbox="346.9 231.03 351.49 234.6" cid="1" code="0xf0b7" fid="21:0"/> Reliance on major customers that have decreased<inno:br/>operations<inno:br/><inno:nec bbox="346.9 207.23 351.49 210.8" cid="1" code="0xf0b7" fid="21:0"/> Disruption to supply chains<inno:br/><inno:nec bbox="346.9 194.93 351.49 198.5" cid="1" code="0xf0b7" fid="21:0"/> Temporary or longer-term delays to projects and<inno:br/>development plans<inno:br/><inno:nec bbox="346.9 171.13 351.49 174.7" cid="1" code="0xf0b7" fid="21:0"/> Financial statement impacts related to<inno:br/>restructuring, impairment and measurement<inno:br/>uncertainty<inno:br/><inno:nec bbox="346.9 135.83 351.49 139.4" cid="1" code="0xf0b7" fid="21:0"/> Change to consumer behaviour resulting from the<inno:br/>pandemic and impact to future operations<inno:br/><inno:nec bbox="346.9 112.03 351.49 115.6" cid="1" code="0xf0b7" fid="21:0"/> Additional litigation risks resulting from the<inno:br/>pandemic<inno:br/><inno:nec bbox="346.9 88.23 351.49 91.8" cid="1" code="0xf0b7" fid="21:0"/> The issuer’s ability to recover from the pandemic<inno:br/>that may be unique to the issuer or its industry</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-76" type="text"><inno:block page="11" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-13-</inno:font></inno:block></inno:text><inno:table id="table-8" type="table"><inno:block page="11" page-height="512" page-width="396" x-max="363.0" x-min="46.0" y-max="75.0" y-min="42.0"><inno:tr row="1">
<inno:td col="1" id="table-8-1-1" x-max="120.0" x-min="46.0" y-max="55.0" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-8-1-2" x-max="202.5" x-min="120.0" y-max="55.0" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-8-1-3" x-max="363.0" x-min="202.5" y-max="55.0" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-8-2-1" x-max="120.0" x-min="46.0" y-max="75.0" y-min="55.0"/>
<inno:td col="2" id="table-8-2-2" x-max="202.5" x-min="120.0" y-max="75.0" y-min="55.0"/>
<inno:td col="3" id="table-8-2-3" x-max="363.0" x-min="202.5" y-max="75.0" y-min="55.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Part 1, Item 1.4 of Form 51-102F1, Item<inno:br/>5.2 of Form 51-102F2</inno:font></inno:b></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-77" type="text"><inno:block page="11" page-height="512" page-width="396" x-max="143.0" x-min="43.0" y-max="85.0" y-min="75.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="14.00pt">A.2 Financial Statements</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-78" type="text"><inno:block page="11" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="130.0" y-min="93.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The impact of COVID-19 could be significant for many businesses. Given the continued impact of<inno:br/>COVID-19, there is a higher degree of uncertainty in determining reasonable and supportable<inno:br/>assumptions used in preparing financial statements. Management should carefully consider the impact of<inno:br/>COVID-19 on each of the following key aspects in the financial statements.</inno:font></inno:block></inno:text><inno:table id="table-9" type="table"><inno:block page="11" page-height="512" page-width="396" x-max="364.0" x-min="45.0" y-max="480.0" y-min="134.0"><inno:tr row="1">
<inno:td col="1" id="table-9-1-1" x-max="97.5" x-min="45.0" y-max="145.0" y-min="134.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" colspan="2" id="table-9-1-2" x-max="216.0" x-min="97.5" y-max="145.0" y-min="134.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-9-1-3" x-max="364.0" x-min="216.0" y-max="145.0" y-min="134.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-9-2-1" rowspan="4" x-max="97.5" x-min="45.0" y-max="278.0" y-min="145.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Impairment of<inno:br/>Non-financial<inno:br/>Assets</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-9-2-2" x-max="150.05" x-min="97.5" y-max="153.95" y-min="145.0"><inno:nec bbox="170.6 553.84 176.11 558.12" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Events and</inno:font></inno:td>
<inno:td col="3" id="table-9-2-3" rowspan="2" x-max="216.0" x-min="150.05" y-max="157.05" y-min="145.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">circumstances most</inno:font></inno:td>
<inno:td col="4" id="table-9-2-4" rowspan="4" x-max="364.0" x-min="216.0" y-max="278.0" y-min="145.0"><inno:nec bbox="339.5 553.84 345.01 558.12" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Disclose the key assumptions on which<inno:br/>management based its determination of the<inno:br/>recoverable amount.<inno:br/><inno:nec bbox="339.5 516.04 345.01 520.32" cid="1" code="0xf0b7" fid="21:0"/> Consider whether using probability weighted<inno:br/>scenarios in making estimates of fair value or<inno:br/>value in use is more appropriate than a single<inno:br/>best estimate.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">For issuers with investments in associates or joint<inno:br/>ventures accounted for using equity method</inno:font></inno:b><inno:br/><inno:nec bbox="339.5 432.04 345.01 436.32" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers should carefully analyze the impact of<inno:br/>COVID-19 on the operations and financial<inno:br/>conditions of their associates and joint ventures<inno:br/>to consider whether there is a ‘loss event’ that<inno:br/>has an impact on the future cash flows of the<inno:br/>investment.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-9-3-1" rowspan="2" x-max="150.05" x-min="97.5" y-max="163.05" y-min="153.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">commonly</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-9-4-1" x-max="216.0" x-min="150.05" y-max="163.05" y-min="157.05"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">identified by issuers as</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" colspan="2" id="table-9-5-1" rowspan="2" x-max="216.0" x-min="97.5" y-max="377.5" y-min="163.05"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">indications of impairment and that<inno:br/>led to the recognition of<inno:br/>impairment losses in connection<inno:br/>with COVID-19 included:<inno:br/>decreased demand for the issuer’s<inno:br/>products or services, significant<inno:br/>customers experiencing financial<inno:br/>difficulties and increased<inno:br/>costs/business interruption due to<inno:br/>supply chain issues.<inno:br/><inno:nec bbox="170.6 412.14 176.11 416.42" cid="1" code="0xf0b7" fid="21:0"/> A few issuers did not identify the<inno:br/>events or circumstances that led to<inno:br/>an impairment or simply noted<inno:br/>“negative economic impacts of<inno:br/>COVID-19” as an impairment<inno:br/>indicator for all CGUs but did not<inno:br/>elaborate on those impacts.<inno:br/><inno:nec bbox="170.6 328.14 176.11 332.42" cid="1" code="0xf0b7" fid="21:0"/> Approximately 10% of the issuers<inno:br/>we reviewed did not disclose or<inno:br/>update the disclosure of the key<inno:br/>assumptions used in their<inno:br/>impairment calculations.</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-9-6-1" x-max="97.5" x-min="45.0" y-max="377.5" y-min="278.0"/>
<inno:td col="2" id="table-9-6-2" x-max="364.0" x-min="216.0" y-max="377.5" y-min="278.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Other considerations:</inno:font></inno:b><inno:br/><inno:nec bbox="339.5 338.33 344.09 341.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Whether there is any indication that an asset has<inno:br/>been impaired in an interim period, which would<inno:br/>then require the issuer to estimate the recoverable<inno:br/>amount of the asset in the period (e.g., a significant<inno:br/>decrease in an issuer’s share price during the<inno:br/>reporting period such that market capitalization is<inno:br/>lower than carrying value).<inno:br/><inno:nec bbox="339.5 256.73 344.09 260.3" cid="1" code="0xf0b7" fid="21:0"/> Disclosure may be required for changes in key<inno:br/>assumptions used to determine recoverable amount<inno:br/>of a CGU that contains goodwill or intangible assets<inno:br/>with indefinite useful lives.</inno:font></inno:td>
</inno:tr>
<inno:tr row="7">
<inno:td col="1" id="table-9-7-1" x-max="97.5" x-min="45.0" y-max="406.0" y-min="377.5"/>
<inno:td col="2" id="table-9-7-2" x-max="150.05" x-min="97.5" y-max="406.0" y-min="377.5"/>
<inno:td col="3" id="table-9-7-3" x-max="216.0" x-min="150.05" y-max="406.0" y-min="377.5"/>
<inno:td col="4" id="table-9-7-4" x-max="364.0" x-min="216.0" y-max="406.0" y-min="377.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: International Accounting Standards<inno:br/>(IAS) 36</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Impairment of assets,</inno:i></inno:font> <inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">para. 41A of IAS 28</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Investments in Associates and Joint Ventures</inno:i></inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="8">
<inno:td col="1" id="table-9-8-1" x-max="97.5" x-min="45.0" y-max="480.0" y-min="406.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Going Concern</inno:font></inno:b></inno:td>
<inno:td col="2" colspan="2" id="table-9-8-2" x-max="216.0" x-min="97.5" y-max="480.0" y-min="406.0"><inno:nec bbox="170.6 151.14 176.11 155.42" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">A few issuers identified material<inno:br/>uncertainties that cast significant<inno:br/>doubt on their ability to continue<inno:br/>as a going concern in light of a<inno:br/>deterioration in their business<inno:br/>since the onset of the pandemic.<inno:br/><inno:nec bbox="170.6 78.64 176.11 82.92" cid="1" code="0xf0b7" fid="21:0"/> Some issuers disclosed “close<inno:br/>call” situations but did not<inno:br/>disclose the mitigating actions that</inno:font></inno:td>
<inno:td col="3" id="table-9-8-3" x-max="364.0" x-min="216.0" y-max="480.0" y-min="406.0"><inno:nec bbox="339.83 151.14 346.49 155.42" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">If issuers breach debt covenants prior to the<inno:br/>financial statement date and the lender has the<inno:br/>right to demand repayment, the issuer is required<inno:br/>to reclassify the loan as current and should<inno:br/>discuss the implications of such breach on their<inno:br/>ability to continue as a going concern.<inno:br/><inno:nec bbox="339.5 78.64 345.01 82.92" cid="1" code="0xf0b7" fid="21:0"/> If an issuer is working with its lenders to change<inno:br/>terms of existing debt agreements or to obtain<inno:br/>waivers for debt covenants, it should closely</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-79" type="text"><inno:block page="12" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="31.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-14-</inno:font></inno:block></inno:text><inno:table id="table-10" type="table"><inno:block page="12" page-height="512" page-width="396" x-max="364.0" x-min="45.0" y-max="477.0" y-min="43.0"><inno:tr row="1">
<inno:td col="1" id="table-10-1-1" x-max="100.5" x-min="45.0" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" colspan="2" id="table-10-1-2" x-max="217.0" x-min="100.5" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-10-1-3" x-max="253.05" x-min="217.0" y-max="54.0" y-min="43.0"/>
<inno:td col="4" colspan="3" id="table-10-1-4" x-max="320.0" x-min="253.05" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
<inno:td col="5" id="table-10-1-5" x-max="364.0" x-min="320.0" y-max="54.0" y-min="43.0"/>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-10-2-1" x-max="100.5" x-min="45.0" y-max="66.95" y-min="54.0"/>
<inno:td col="2" colspan="2" id="table-10-2-2" x-max="217.0" x-min="100.5" y-max="66.95" y-min="54.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">impacted their determination that<inno:br/>there were no material</inno:font></inno:td>
<inno:td col="3" colspan="5" id="table-10-2-3" rowspan="3" x-max="364.0" x-min="217.0" y-max="82.95" y-min="54.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">examine changes to its debt agreements to assess<inno:br/>whether they are subject to modification or<inno:br/>extinguishment accounting, as required by IFRS<inno:br/>9</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="10.00pt"><inno:i>Financial Instruments</inno:i></inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-10-3-1" x-max="100.5" x-min="45.0" y-max="78.0" y-min="66.95"/>
<inno:td col="2" id="table-10-3-2" x-max="157.0" x-min="100.5" y-max="78.0" y-min="66.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">t ere were no<inno:br/>uncertainties</inno:font></inno:td>
<inno:td col="3" id="table-10-3-3" x-max="217.0" x-min="157.0" y-max="78.0" y-min="66.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">mater a<inno:br/>that cast significant</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-10-4-1" x-max="100.5" x-min="45.0" y-max="82.95" y-min="78.0"/>
<inno:td col="2" colspan="2" id="table-10-4-2" rowspan="2" x-max="217.0" x-min="100.5" y-max="94.0" y-min="78.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">doubt on the issuer’s ability to<inno:br/>continue as a going concern.</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-10-5-1" x-max="100.5" x-min="45.0" y-max="94.0" y-min="82.95"/>
<inno:td col="2" id="table-10-5-2" x-max="253.05" x-min="217.0" y-max="94.0" y-min="82.95"><inno:nec bbox="339.5 649.74 345.01 654.02" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">When m</inno:font></inno:td>
<inno:td col="3" id="table-10-5-3" x-max="278.95" x-min="253.05" y-max="94.0" y-min="82.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">anagemen</inno:font></inno:td>
<inno:td col="4" id="table-10-5-4" x-max="310.05" x-min="278.95" y-max="94.0" y-min="82.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">t is aware of</inno:font></inno:td>
<inno:td col="5" colspan="2" id="table-10-5-5" x-max="364.0" x-min="310.05" y-max="94.0" y-min="82.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">f material</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-10-6-1" x-max="100.5" x-min="45.0" y-max="101.5" y-min="94.0"/>
<inno:td col="2" colspan="2" id="table-10-6-2" x-max="217.0" x-min="100.5" y-max="101.5" y-min="94.0"><inno:nec bbox="170.6 638.24 176.11 642.52" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers breached financial</inno:font></inno:td>
<inno:td col="3" colspan="5" id="table-10-6-3" rowspan="4" x-max="364.0" x-min="217.0" y-max="284.95" y-min="94.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">uncertainties in relation to COVID-19 that may<inno:br/>cast significant doubt upon the issuer’s ability to<inno:br/>continue as a going concern, those uncertainties<inno:br/>are required to be disclosed.<inno:br/><inno:nec bbox="339.5 588.84 345.01 593.12" cid="1" code="0xf0b7" fid="21:0"/> If management determined there were no<inno:br/>material uncertainties that cast significant doubt<inno:br/>on the issuer’s ability to continue as a going<inno:br/>concern, but there were significant doubts about<inno:br/>going concern that were addressed by mitigating<inno:br/>actions judged sufficient to conclude the going<inno:br/>concern basis of accounting is appropriate, then<inno:br/>such situations are commonly referred to as a<inno:br/>“close call”. In these situations, issuers are<inno:br/>required to disclose the significant judgments to<inno:br/>support their determination that going concern is<inno:br/>appropriate, including those mitigating actions<inno:br/>that impacted their determination that material<inno:br/>uncertainties have been addressed (i.e.,<inno:br/>successful negotiations of credit facilities<inno:br/>subsequent to period end or the identification of<inno:br/>other feasible sources of financing).</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">References: para. 25 and 122 of IAS 1</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Presentation<inno:br/>of Financial Statements,</inno:i></inno:font> <inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">IFRS 9</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Financial<inno:br/>Instruments</inno:i></inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="7">
<inno:td col="1" id="table-10-7-1" x-max="100.5" x-min="45.0" y-max="111.05" y-min="101.5"/>
<inno:td col="2" colspan="2" id="table-10-7-2" x-max="217.0" x-min="100.5" y-max="111.05" y-min="101.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">covenants during the reporting</inno:font></inno:td>
</inno:tr>
<inno:tr row="8">
<inno:td col="1" id="table-10-8-1" x-max="100.5" x-min="45.0" y-max="220.5" y-min="111.05"/>
<inno:td col="2" colspan="2" id="table-10-8-2" x-max="217.0" x-min="100.5" y-max="220.5" y-min="111.05"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">periods but did not:</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">disclose how the breaches<inno:br/>will impact the company's<inno:br/>ability to continue as a going<inno:br/>concern, or</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">reclassify the loan as a<inno:br/>current liability.</inno:font></inno:td>
</inno:tr>
<inno:tr row="9">
<inno:td col="1" id="table-10-9-1" rowspan="2" x-max="100.5" x-min="45.0" y-max="424.0" y-min="220.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Significant<inno:br/>Judgements and<inno:br/>Measurement<inno:br/>Uncertainties</inno:font></inno:td>
<inno:td col="2" colspan="2" id="table-10-9-2" rowspan="3" x-max="217.0" x-min="100.5" y-max="477.0" y-min="220.5"><inno:nec bbox="170.6 342.44 176.11 346.72" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">While many issuers updated their<inno:br/>disclosure since March 2020<inno:br/>regarding significant judgements<inno:br/>and measurement uncertainties,<inno:br/>notably with respect to the<inno:br/>impairment of non-financial<inno:br/>assets, going concern analysis and<inno:br/>the estimate of credit losses and<inno:br/>credit risks, a number of issuers<inno:br/>only stated in their interim<inno:br/>financial statements that the<inno:br/>significant judgements and<inno:br/>measurement uncertainties<inno:br/>remained the same as those<inno:br/>disclosed in the issuers’ most<inno:br/>recent annual financial statements.<inno:br/><inno:nec bbox="170.6 154.44 176.11 158.72" cid="1" code="0xf0b7" fid="21:0"/> About 30% of the issuers we<inno:br/>reviewed with material sources of<inno:br/>measurement uncertainty related<inno:br/>to COVID-19 did not disclose the<inno:br/>expected resolutions of the<inno:br/>uncertainty or the range of<inno:br/>reasonably possible outcomes<inno:br/>within the next financial year.<inno:br/><inno:nec bbox="170.6 58.94 176.11 63.22" cid="1" code="0xf0b7" fid="21:0"/> Some issuers only disclosed</inno:font></inno:td>
</inno:tr>
<inno:tr row="10">
<inno:td col="1" colspan="5" id="table-10-10-1" x-max="364.0" x-min="217.0" y-max="424.0" y-min="284.95"><inno:nec bbox="339.5 342.44 345.01 346.72" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers that operate in sectors that are<inno:br/>significantly affected by COVID-19 are expected<inno:br/>to update the following disclosure in their<inno:br/>interim and annual financial statements:</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">timely and entity-specific disclosure of<inno:br/>significant judgements and measurement<inno:br/>uncertainties pertaining to the amounts<inno:br/>recognized in the financial statements in<inno:br/>light of the rapidly changing environment<inno:br/>and the extended impact of COVID-19<inno:br/>(e.g., estimate of credit loss and valuation<inno:br/>of non-financial assets); and</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">explanation of the nature of estimation<inno:br/>uncertainty and sensitivity analysis to help<inno:br/>investors fully understand the potential<inno:br/>impact of estimates made in the financial<inno:br/>statements.<inno:br/><inno:nec bbox="339.5 141.34 345.01 145.62" cid="1" code="0xf0b7" fid="21:0"/> While issuers are expected to supplement their</inno:font></inno:td>
</inno:tr>
<inno:tr row="11">
<inno:td col="1" id="table-10-11-1" x-max="100.5" x-min="45.0" y-max="477.0" y-min="424.0"/>
<inno:td col="2" id="table-10-11-2" x-max="253.05" x-min="217.0" y-max="477.0" y-min="424.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">discussio<inno:br/>measure<inno:br/>accounti<inno:br/>looking<inno:br/>judgeme<inno:br/>required<inno:br/>statemen</inno:font></inno:td>
<inno:td col="3" id="table-10-11-3" x-max="278.95" x-min="253.05" y-max="477.0" y-min="424.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">on of signi<inno:br/>ment unce<inno:br/>ng estimat<inno:br/>informatio<inno:br/>nts and m<inno:br/>in the not<inno:br/>ts.</inno:font></inno:td>
<inno:td col="4" id="table-10-11-4" x-max="310.05" x-min="278.95" y-max="477.0" y-min="424.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">ificant judgm<inno:br/>rtainty in th<inno:br/>tes, risk fact<inno:br/>n) the discu<inno:br/>easurement<inno:br/>es to the ann</inno:font></inno:td>
<inno:td col="5" id="table-10-11-5" x-max="320.0" x-min="310.05" y-max="477.0" y-min="424.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">ent<inno:br/>e M<inno:br/>ors,<inno:br/>ssio<inno:br/>unc<inno:br/>nual</inno:font></inno:td>
<inno:td col="6" id="table-10-11-6" x-max="364.0" x-min="320.0" y-max="477.0" y-min="424.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">s and<inno:br/>D&amp;A (critical<inno:br/>forward<inno:br/>n of significant<inno:br/>ertainty is<inno:br/>financial</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-80" type="text"><inno:block page="13" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="31.0" y-min="23.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-15-</inno:font></inno:block></inno:text><inno:table id="table-11" type="table"><inno:block page="13" page-height="512" page-width="396" x-max="363.0" x-min="44.0" y-max="478.0" y-min="44.0"><inno:tr row="1">
<inno:td col="1" id="table-11-1-1" x-max="99.5" x-min="44.0" y-max="55.5" y-min="44.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-11-1-2" x-max="215.05" x-min="99.5" y-max="55.5" y-min="44.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-11-1-3" x-max="363.0" x-min="215.05" y-max="55.5" y-min="44.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-11-2-1" x-max="99.5" x-min="44.0" y-max="79.5" y-min="55.5"/>
<inno:td col="2" id="table-11-2-2" x-max="215.05" x-min="99.5" y-max="79.5" y-min="55.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">significant judgements in their<inno:br/>MD&amp;A but not in their financial<inno:br/>statements.</inno:font></inno:td>
<inno:td col="3" id="table-11-2-3" rowspan="2" x-max="363.0" x-min="215.05" y-max="478.0" y-min="55.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">References: para 122 and 125 of IAS 1</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Presentation of Financial Statements</inno:i></inno:font></inno:b><inno:br/><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers are required to disclose the following:<inno:br/><inno:nec bbox="339.5 643.04 345.01 647.32" cid="1" code="0xf0b7" fid="21:0"/> An explanation of the inputs, assumptions and<inno:br/>judgments made in estimating ECL<inno:br/><inno:nec bbox="339.5 616.74 345.01 621.02" cid="1" code="0xf0b7" fid="21:0"/> The quantitative and qualitative factors taken<inno:br/>into account in determining what constitutes a<inno:br/>SICR<inno:br/><inno:nec bbox="339.5 578.94 345.01 583.22" cid="1" code="0xf0b7" fid="21:0"/> An issuer’s definitions of default, including the<inno:br/>reasons for selecting those definitions<inno:br/><inno:nec bbox="339.5 552.74 345.01 557.02" cid="1" code="0xf0b7" fid="21:0"/> An issuer’s write-off policy, including the<inno:br/>indicators that there is no reasonable expectation<inno:br/>of recovery<inno:br/><inno:nec bbox="339.5 514.94 345.01 519.22" cid="1" code="0xf0b7" fid="21:0"/> How forward-looking information has been<inno:br/>incorporated into the determination of ECL.<inno:br/>Forward-looking information can include<inno:br/>macroeconomic information, for example:<inno:br/>unemployment rate, GDP growth rate, housing<inno:br/>price index/home price index growth rate, and<inno:br/>interest rate forecasts. Staff expect that forward-<inno:br/>looking information should take COVID-19<inno:br/>impacts into consideration.<inno:br/><inno:nec bbox="339.5 407.84 345.01 412.12" cid="1" code="0xf0b7" fid="21:0"/> Information about credit risk management<inno:br/>practices and any significant changes to credit<inno:br/>risk exposure, which may in part be due to the<inno:br/>impact of COVID-19.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Other considerations:</inno:font></inno:b><inno:br/><inno:nec bbox="339.5 337.13 344.09 340.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Relying solely on historic loss rates in determining<inno:br/>ECL would not be appropriate if the entity has been,<inno:br/>or is expected to be, impacted by the pandemic.<inno:br/><inno:nec bbox="339.5 301.83 344.09 305.4" cid="1" code="0xf0b7" fid="21:0"/> It may be difficult at this time to incorporate the<inno:br/>specific effects of the pandemic (e.g. government<inno:br/>support and customer relief measures) into the ECL<inno:br/>models as systems may not be calibrated to address<inno:br/>the impacts of COVID-19. When it is not possible<inno:br/>to reflect such information in models, issuers should<inno:br/>consider post-model overlays or adjustments, and<inno:br/>provide adequate disclosure of those overlays and<inno:br/>adjustments.<inno:br/><inno:nec bbox="339.5 185.63 344.09 189.2" cid="1" code="0xf0b7" fid="21:0"/> Other disclosure considerations include:</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The values of the key macroeconomic inputs used in<inno:br/>the multiple economic scenario analysis and the<inno:br/>probability weights of these scenarios.</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The assumptions used to determine how the<inno:br/>different challenges for specific sectors and regions<inno:br/>have been taken into account.</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">If material, issuers may consider disclosing further<inno:br/>details about payment deferral programs such as the<inno:br/>amount and nature of the total principal balance<inno:br/>outstanding within payment deferral/payment<inno:br/>holiday programs provided to borrowers as a result</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-11-3-1" x-max="99.5" x-min="44.0" y-max="478.0" y-min="79.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Expected Credit<inno:br/>Losses (ECL)</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-11-3-2" x-max="215.05" x-min="99.5" y-max="478.0" y-min="79.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Financial Institutions</inno:font></inno:b><inno:br/><inno:nec bbox="170.6 643.04 176.11 647.32" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers disclosed an elevated<inno:br/>level of credit risk on their<inno:br/>material financial assets by each<inno:br/>asset class in light of the outbreak<inno:br/>of COVID-19 and updated the key<inno:br/>assumptions considered by<inno:br/>management and their strategies to<inno:br/>strengthen their risk profile (e.g.,<inno:br/>through temporarily reducing risk<inno:br/>appetite for certain asset classes or<inno:br/>increasing loan-to-value ratios).<inno:br/><inno:nec bbox="170.6 512.84 176.11 517.12" cid="1" code="0xf0b7" fid="21:0"/> Some issuers disclosed increased<inno:br/>ECL or provided an adequate<inno:br/>explanation regarding their<inno:br/>expectation that COVID-19 will<inno:br/>not significantly impair their<inno:br/>capital position and credit quality.<inno:br/><inno:nec bbox="170.6 440.34 176.11 444.62" cid="1" code="0xf0b7" fid="21:0"/> Many issuers that provided loan<inno:br/>deferral programs/payment<inno:br/>holidays to borrowers during<inno:br/>COVID-19 pandemic also<inno:br/>discussed the impact of these<inno:br/>changes on risk of default and<inno:br/>discussed the impact of these<inno:br/>deferrals, including that the<inno:br/>deferral of payments may not<inno:br/>immediately or always result in a<inno:br/>significant increase in credit risk<inno:br/>(SICR).<inno:br/><inno:nec bbox="170.6 298.64 176.11 302.92" cid="1" code="0xf0b7" fid="21:0"/> Some issuers did not update their<inno:br/>sensitivity analysis or disclose<inno:br/>adjustments/overlays to the ECL<inno:br/>model in their financial statements<inno:br/>that may have been necessary due<inno:br/>to COVID-19 pandemic.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</inno:font></inno:b><inno:br/><inno:nec bbox="170.6 203.04 176.11 207.32" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers used sensitivity<inno:br/>analysis with respect to the ECL<inno:br/>model by providing multi-factor<inno:br/>sensitivities to show the impact of<inno:br/>possible changes in multiple<inno:br/>assumptions affecting the ECL<inno:br/>allowance.<inno:br/><inno:nec bbox="170.6 119.04 176.11 123.32" cid="1" code="0xf0b7" fid="21:0"/> A few issuers tailored the forward-<inno:br/>looking information incorporated<inno:br/>in determining their ECL to reflect<inno:br/>the changes in characteristics of<inno:br/>individual loan books (e.g.,<inno:br/>changes of credit risk in loans</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-81" type="text"><inno:block page="14" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="31.0" y-min="23.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-16-</inno:font></inno:block></inno:text><inno:table id="table-12" type="table"><inno:block page="14" page-height="512" page-width="396" x-max="362.0" x-min="45.0" y-max="472.0" y-min="43.0"><inno:tr row="1">
<inno:td col="1" id="table-12-1-1" x-max="103.0" x-min="45.0" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" colspan="2" id="table-12-1-2" x-max="217.0" x-min="103.0" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-12-1-3" x-max="252.5" x-min="217.0" y-max="54.0" y-min="43.0"/>
<inno:td col="4" id="table-12-1-4" x-max="254.95" x-min="252.5" y-max="54.0" y-min="43.0"/>
<inno:td col="5" id="table-12-1-5" x-max="276.05" x-min="254.95" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Co</inno:font></inno:b></inno:td>
<inno:td col="6" id="table-12-1-6" x-max="276.95" x-min="276.05" y-max="54.0" y-min="43.0"/>
<inno:td col="7" id="table-12-1-7" x-max="280.95" x-min="276.95" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">n</inno:font></inno:b></inno:td>
<inno:td col="8" id="table-12-1-8" x-max="307.05" x-min="280.95" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">sideration</inno:font></inno:b></inno:td>
<inno:td col="9" id="table-12-1-9" x-max="307.95" x-min="307.05" y-max="54.0" y-min="43.0"/>
<inno:td col="10" id="table-12-1-10" x-max="316.95" x-min="307.95" y-max="54.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">s</inno:font></inno:b></inno:td>
<inno:td col="11" id="table-12-1-11" x-max="362.0" x-min="316.95" y-max="54.0" y-min="43.0"/>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-12-2-1" x-max="103.0" x-min="45.0" y-max="66.95" y-min="54.0"/>
<inno:td col="2" colspan="2" id="table-12-2-2" x-max="217.0" x-min="103.0" y-max="66.95" y-min="54.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">provided to borrowers in<inno:br/>vulnerable sectors/ eo ra hic</inno:font></inno:td>
<inno:td col="3" colspan="9" id="table-12-2-3" rowspan="3" x-max="362.0" x-min="217.0" y-max="105.5" y-min="54.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">of COVID-19. Issuers may also consider disclosing<inno:br/>total mortgages previously included in payment<inno:br/>deferral programs that are now included in total<inno:br/>mortgage arrears to provide investors with timely<inno:br/>and transparent disclosure of the impact of such<inno:br/>programs.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-12-3-1" x-max="103.0" x-min="45.0" y-max="77.05" y-min="66.95"/>
<inno:td col="2" id="table-12-3-2" x-max="164.95" x-min="103.0" y-max="77.05" y-min="66.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">vu nera e secto<inno:br/>regions or of hig</inno:font></inno:td>
<inno:td col="3" id="table-12-3-3" x-max="217.0" x-min="164.95" y-max="77.05" y-min="66.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">rs geograp c<inno:br/>her downgrade</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-12-4-1" x-max="103.0" x-min="45.0" y-max="105.5" y-min="77.05"/>
<inno:td col="2" colspan="2" id="table-12-4-2" rowspan="3" x-max="217.0" x-min="103.0" y-max="191.95" y-min="77.05"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">sensitivity)</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers Applying the “simplified”<inno:br/>ECL model</inno:font></inno:b><inno:br/><inno:nec bbox="170.6 626.64 176.11 630.92" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Over 20% of the issuers we<inno:br/>reviewed did not disclose<inno:br/>ECL/allowance for doubtful<inno:br/>accounts for their significant<inno:br/>accounts receivable balance, or<inno:br/>did not provide sufficiently<inno:br/>detailed updates to the<inno:br/>measurement of ECL due to the<inno:br/>COVID-19 outbreak (e.g., the<inno:br/>adjustment for key assumptions<inno:br/>and change in grouping of trade<inno:br/>receivables).</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-12-5-1" x-max="103.0" x-min="45.0" y-max="161.0" y-min="105.5"/>
<inno:td col="2" colspan="9" id="table-12-5-2" x-max="362.0" x-min="217.0" y-max="161.0" y-min="105.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: para 5.5.11 of IFRS 9</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Financial<inno:br/>Instruments, IFRS 7</inno:i></inno:font> <inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Financial Instruments:<inno:br/>Disclosure</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-12-6-1" x-max="103.0" x-min="45.0" y-max="191.95" y-min="161.0"/>
<inno:td col="2" id="table-12-6-2" rowspan="2" x-max="252.5" x-min="217.0" y-max="200.05" y-min="161.0"><inno:nec bbox="339.5 484.14 345.01 488.42" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers a</inno:font></inno:td>
<inno:td col="3" colspan="3" id="table-12-6-3" rowspan="2" x-max="276.95" x-min="252.5" y-max="200.05" y-min="161.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">are require</inno:font></inno:td>
<inno:td col="4" colspan="3" id="table-12-6-4" rowspan="2" x-max="307.95" x-min="276.95" y-max="200.05" y-min="161.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">ed to disclos</inno:font></inno:td>
<inno:td col="5" colspan="2" id="table-12-6-5" rowspan="2" x-max="362.0" x-min="307.95" y-max="200.05" y-min="161.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">e the extent to</inno:font></inno:td>
</inno:tr>
<inno:tr row="7">
<inno:td col="1" id="table-12-7-1" rowspan="2" x-max="103.0" x-min="45.0" y-max="380.95" y-min="191.95"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">FV Changes for<inno:br/>Real Estate<inno:br/>Industry</inno:font></inno:b></inno:td>
<inno:td col="2" colspan="2" id="table-12-7-2" rowspan="2" x-max="217.0" x-min="103.0" y-max="380.95" y-min="191.95"><inno:nec bbox="170.6 485.93 175.19 489.5" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers did not disclose in<inno:br/>sufficient detail the inputs used in<inno:br/>determining FV or discuss the<inno:br/>sensitivity of level 3 fair value<inno:br/>measurements to changes in<inno:br/>unobservable inputs.</inno:font></inno:td>
</inno:tr>
<inno:tr row="8">
<inno:td col="1" colspan="9" id="table-12-8-1" x-max="362.0" x-min="217.0" y-max="380.95" y-min="200.05"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">which the FV of an investment property has been<inno:br/>independently valued (or the fact that there has<inno:br/>been no such independent valuation).<inno:br/><inno:nec bbox="339.5 434.84 345.01 439.12" cid="1" code="0xf0b7" fid="21:0"/> Issuers should consider disclosing qualitative<inno:br/>factors impacting the fair values of commercial<inno:br/>properties, including, for example:</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Possible changes in consumer preferences<inno:br/>between retail and online shopping</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Changes in the financial condition of<inno:br/>existing tenants</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Restructuring of agreements with tenants.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers with material assets measured using level 3<inno:br/>inputs</inno:font></inno:b><inno:br/><inno:nec bbox="339.5 302.24 345.01 306.52" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers are required include a narrative<inno:br/>description of the sensitivity of recurring fair<inno:br/>value measurements to changes in unobservable<inno:br/>level 3 inputs if a change in those inputs might<inno:br/>result in a significantly higher or lower fair value<inno:br/>measurement. Examples of unobservable inputs<inno:br/>may include discount rates, interest rates on<inno:br/>loans, and terminal capitalization rates.</inno:font></inno:td>
</inno:tr>
<inno:tr row="9">
<inno:td col="1" id="table-12-9-1" x-max="103.0" x-min="45.0" y-max="393.5" y-min="380.95"/>
<inno:td col="2" id="table-12-9-2" x-max="164.95" x-min="103.0" y-max="393.5" y-min="380.95"/>
<inno:td col="3" id="table-12-9-3" x-max="217.0" x-min="164.95" y-max="393.5" y-min="380.95"/>
<inno:td col="4" colspan="9" id="table-12-9-4" x-max="362.0" x-min="217.0" y-max="393.5" y-min="380.95"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: para. 93(h)(i) of IFRS 13</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Fair Value<inno:br/>Measurement,</inno:i></inno:font> <inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">IAS 40</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Investment Property</inno:i></inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="10">
<inno:td col="1" id="table-12-10-1" rowspan="3" x-max="103.0" x-min="45.0" y-max="418.95" y-min="393.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Financial<inno:br/>Instrument Risk<inno:br/>Disclosures</inno:font></inno:b></inno:td>
<inno:td col="2" colspan="2" id="table-12-10-2" rowspan="8" x-max="217.0" x-min="103.0" y-max="468.05" y-min="393.5"><inno:nec bbox="170.6 171.24 176.11 175.52" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">We noted issuers that disclosed<inno:br/>material impacts of COVID-19 on<inno:br/>their business operations in their<inno:br/>MD&amp;A appeared to have<inno:br/>increased their<inno:br/>liquidity/market/credit risk but did<inno:br/>not provide an entity-specific<inno:br/>update to their risk disclosure in<inno:br/>the financial statements.</inno:font></inno:td>
<inno:td col="3" colspan="9" id="table-12-10-3" x-max="362.0" x-min="217.0" y-max="401.95" y-min="393.5"><inno:nec bbox="339.5 171.24 345.01 175.52" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers should carefully consider whether there</inno:font></inno:td>
</inno:tr>
<inno:tr row="11">
<inno:td col="1" colspan="2" id="table-12-11-1" x-max="254.95" x-min="217.0" y-max="412.05" y-min="401.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">have bee</inno:font></inno:td>
<inno:td col="2" colspan="3" id="table-12-11-2" x-max="280.95" x-min="254.95" y-max="412.05" y-min="401.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">n changes</inno:font></inno:td>
<inno:td col="3" id="table-12-11-3" x-max="307.05" x-min="280.95" y-max="412.05" y-min="401.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">to their cr</inno:font></inno:td>
<inno:td col="4" colspan="3" id="table-12-11-4" x-max="362.0" x-min="307.05" y-max="412.05" y-min="401.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">edit risk. The</inno:font></inno:td>
</inno:tr>
<inno:tr row="12">
<inno:td col="1" colspan="9" id="table-12-12-1" x-max="362.0" x-min="217.0" y-max="418.95" y-min="412.05"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">following factors may be taken into</inno:font></inno:td>
</inno:tr>
<inno:tr row="13">
<inno:td col="1" id="table-12-13-1" x-max="103.0" x-min="45.0" y-max="429.0" y-min="418.95"/>
<inno:td col="2" colspan="9" id="table-12-13-2" x-max="362.0" x-min="217.0" y-max="429.0" y-min="418.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">consideration in assessing credit risk:</inno:font></inno:td>
</inno:tr>
<inno:tr row="14">
<inno:td col="1" id="table-12-14-1" x-max="103.0" x-min="45.0" y-max="443.0" y-min="429.0"/>
<inno:td col="2" colspan="3" id="table-12-14-2" x-max="276.05" x-min="217.0" y-max="443.0" y-min="429.0"><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Risk concen</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Significant r</inno:font></inno:td>
<inno:td col="3" colspan="5" id="table-12-14-3" x-max="316.95" x-min="276.05" y-max="443.0" y-min="429.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">trations<inno:br/>risk in ECL (i.e.</inno:font></inno:td>
<inno:td col="4" id="table-12-14-4" x-max="362.0" x-min="316.95" y-max="443.0" y-min="429.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">, financial</inno:font></inno:td>
</inno:tr>
<inno:tr row="15">
<inno:td col="1" id="table-12-15-1" x-max="103.0" x-min="45.0" y-max="451.0" y-min="443.0"/>
<inno:td col="2" colspan="9" id="table-12-15-2" x-max="362.0" x-min="217.0" y-max="451.0" y-min="443.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">condition of specific lenders/clients)</inno:font></inno:td>
</inno:tr>
<inno:tr row="16">
<inno:td col="1" id="table-12-16-1" x-max="103.0" x-min="45.0" y-max="456.95" y-min="451.0"/>
<inno:td col="2" colspan="9" id="table-12-16-2" x-max="362.0" x-min="217.0" y-max="456.95" y-min="451.0"><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Significant assumptions underlying ECL</inno:font></inno:td>
</inno:tr>
<inno:tr row="17">
<inno:td col="1" id="table-12-17-1" x-max="103.0" x-min="45.0" y-max="468.05" y-min="456.95"/>
<inno:td col="2" colspan="6" id="table-12-17-2" x-max="307.05" x-min="217.0" y-max="468.05" y-min="456.95"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">measurement</inno:font></inno:td>
<inno:td col="3" id="table-12-17-3" x-max="307.95" x-min="307.05" y-max="468.05" y-min="456.95"/>
<inno:td col="4" id="table-12-17-4" x-max="316.95" x-min="307.95" y-max="468.05" y-min="456.95"/>
<inno:td col="5" id="table-12-17-5" x-max="362.0" x-min="316.95" y-max="468.05" y-min="456.95"/>
</inno:tr>
<inno:tr row="18">
<inno:td col="1" id="table-12-18-1" x-max="103.0" x-min="45.0" y-max="472.0" y-min="468.05"/>
<inno:td col="2" id="table-12-18-2" x-max="164.95" x-min="103.0" y-max="472.0" y-min="468.05"/>
<inno:td col="3" id="table-12-18-3" x-max="217.0" x-min="164.95" y-max="472.0" y-min="468.05"/>
<inno:td col="4" colspan="9" id="table-12-18-4" x-max="362.0" x-min="217.0" y-max="472.0" y-min="468.05"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers should also consider updating the</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-82" type="text"><inno:block page="15" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-17-</inno:font></inno:block></inno:text><inno:table id="table-13" type="table"><inno:block page="15" page-height="512" page-width="396" x-max="364.0" x-min="45.0" y-max="422.0" y-min="42.0"><inno:tr row="1">
<inno:td col="1" id="table-13-1-1" x-max="106.5" x-min="45.0" y-max="53.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-13-1-2" x-max="216.0" x-min="106.5" y-max="53.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-13-1-3" x-max="364.0" x-min="216.0" y-max="53.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-13-2-1" x-max="106.5" x-min="45.0" y-max="74.0" y-min="53.5"/>
<inno:td col="2" id="table-13-2-2" x-max="216.0" x-min="106.5" y-max="74.0" y-min="53.5"/>
<inno:td col="3" id="table-13-2-3" x-max="364.0" x-min="216.0" y-max="74.0" y-min="53.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">disclosure of their credit risk management<inno:br/>practices accordingly.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-13-3-1" x-max="106.5" x-min="45.0" y-max="271.0" y-min="74.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Government<inno:br/>Assistance</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-13-3-2" x-max="216.0" x-min="106.5" y-max="271.0" y-min="74.0"><inno:nec bbox="170.6 637.44 176.11 641.72" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Over half of the issuers we<inno:br/>reviewed recognized, or disclosed<inno:br/>in subsequent events, COVID-19<inno:br/>related government grants in their<inno:br/>financial statements since the<inno:br/>outbreak of COVID-19 pandemic,<inno:br/>including but not limited to,<inno:br/>CEWS, Canada Emergency<inno:br/>Commercial Rent Assistance<inno:br/>(CECRA), etc.<inno:br/><inno:nec bbox="170.6 518.84 176.11 523.12" cid="1" code="0xf0b7" fid="21:0"/> Only some issuers included<inno:br/>separate note disclosure in their<inno:br/>financial statements in connection<inno:br/>with the COVID-19 related<inno:br/>government grants.<inno:br/><inno:nec bbox="170.6 457.94 176.11 462.22" cid="1" code="0xf0b7" fid="21:0"/> Some issuers only disclosed that<inno:br/>they have received government<inno:br/>grants for pandemic expenses<inno:br/>without identifying the amount<inno:br/>received, naming the specific<inno:br/>assistance program or disclosing<inno:br/>the accounting policy for<inno:br/>recognizing government grants.</inno:font></inno:td>
<inno:td col="3" id="table-13-3-3" x-max="364.0" x-min="216.0" y-max="271.0" y-min="74.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">References: para. 35A of IFRS 7</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Financial<inno:br/>instruments: Disclosures</inno:i></inno:font></inno:b><inno:br/><inno:nec bbox="339.5 637.44 345.01 641.72" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers are required to disclose the following in<inno:br/>connection with the government assistance<inno:br/>received during the period:</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The accounting policy adopted for<inno:br/>government grants, including the method of<inno:br/>presentation adopted in the financial<inno:br/>statements (e.g. offsetting against expenses<inno:br/>or presenting as a separate financial<inno:br/>statement line item)</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The nature and extent of government grants<inno:br/>recognized in the financial statements</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Unfulfilled conditions and other<inno:br/>contingencies attaching to government<inno:br/>assistance that has been recognized<inno:br/><inno:nec bbox="339.5 470.24 345.01 474.52" cid="1" code="0xf0b7" fid="21:0"/> For issuers that received government loans with<inno:br/>forgiveness options, issuers are required to<inno:br/>disclose the terms and conditions of the<inno:br/>government assistance.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: para. 39 of IAS 20</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Accounting for<inno:br/>Government Grants and Disclosure of Government<inno:br/>Assistance</inno:i></inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-13-4-1" x-max="106.5" x-min="45.0" y-max="378.0" y-min="271.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">COVID-19 Related<inno:br/>Amendments to<inno:br/>IFRS 16 Leases for<inno:br/>Lessees</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-13-4-2" rowspan="2" x-max="216.0" x-min="106.5" y-max="422.0" y-min="271.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The IASB issued amendments to IFRS<inno:br/>16</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="10.00pt"><inno:i>Leases</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">to provide a practical<inno:br/>expedient that allows lessees to elect<inno:br/>not to assess whether a rent concession<inno:br/>is a lease modification. The application<inno:br/>of the practical expedient is permitted,<inno:br/>but not required. In order to apply the<inno:br/>practical expedient, certain conditions<inno:br/>specified in IFRS 16 need to be met.<inno:br/><inno:nec bbox="170.6 259.43 175.19 263.0" cid="1" code="0xf0b7" fid="21:0"/> The vast majority of the issuers we<inno:br/>reviewed with material rent<inno:br/>concessions met the required<inno:br/>conditions, but some did not<inno:br/>sufficiently disclose whether they<inno:br/>applied the practical expedient to<inno:br/>all their rent concessions or only<inno:br/>to some of them, or the amount<inno:br/>recognised in profit or loss as a<inno:br/>result of applying the practical<inno:br/>expedient</inno:font></inno:td>
<inno:td col="3" id="table-13-4-3" x-max="364.0" x-min="216.0" y-max="378.0" y-min="271.0"><inno:nec bbox="339.5 363.43 344.09 367.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">When the practical expedient is elected and<inno:br/>applied, a lessee is required to disclose:</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">it has applied the practical expedient to all its<inno:br/>rent concessions that meet the conditions, or<inno:br/>if not applied to all such rent concessions,<inno:br/>information about the nature of the contracts<inno:br/>to which it has applied the practical<inno:br/>expedient.</inno:font><inno:br/><inno:font font-name="CourierNewPSMT" font-size="10.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">the amount recognised in profit or loss for the<inno:br/>reporting period to reflect changes in lease<inno:br/>payments arising from such rent concessions<inno:br/>to which the lessee has applied the practical<inno:br/>expedient.</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-13-5-1" x-max="106.5" x-min="45.0" y-max="422.0" y-min="378.0"/>
<inno:td col="2" id="table-13-5-2" x-max="364.0" x-min="216.0" y-max="422.0" y-min="378.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: para 46A,46B and 60A of IFRS 16</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Leases</inno:i></inno:font></inno:b></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-83" type="text"><inno:block page="16" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-18-</inno:font></inno:block></inno:text><inno:text id="text-84" type="text"><inno:block page="16" page-height="512" page-width="396" x-max="163.0" x-min="43.0" y-max="54.0" y-min="42.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="14.00pt">A.3 Other Regulatory Matters</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-85" type="text"><inno:block page="16" page-height="512" page-width="396" x-max="337.0" x-min="45.0" y-max="80.0" y-min="61.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Disclosure related to the COVID-19 pandemic may also result in consideration of other regulatory requirements<inno:br/>including the requirements and/or guidance related to the following:</inno:font></inno:block></inno:text><inno:table id="table-14" type="table"><inno:block page="16" page-height="512" page-width="396" x-max="362.0" x-min="45.0" y-max="410.0" y-min="82.0"><inno:tr row="1">
<inno:td col="1" id="table-14-1-1" x-max="99.0" x-min="45.0" y-max="94.0" y-min="82.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-14-1-2" x-max="219.5" x-min="99.0" y-max="94.0" y-min="82.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-14-1-3" x-max="362.0" x-min="219.5" y-max="94.0" y-min="82.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-14-2-1" rowspan="2" x-max="99.0" x-min="45.0" y-max="306.0" y-min="94.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">NGMs Adjusted<inno:br/>for Impacts<inno:br/>Related to<inno:br/>COVID-19</inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="5.20pt"><inno:sup>3</inno:sup></inno:font></inno:td>
<inno:td col="2" id="table-14-2-2" rowspan="2" x-max="219.5" x-min="99.0" y-max="306.0" y-min="94.0"><inno:nec bbox="162.6 633.43 167.19 637.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Less than 5% of the issuers we<inno:br/>reviewed disclosed NGMs adjusted<inno:br/>for impacts related to COVID-19.<inno:br/><inno:nec bbox="162.6 598.13 167.19 601.7" cid="1" code="0xf0b7" fid="21:0"/> In certain cases where a NGM was<inno:br/>disclosed, issuers did not adequately<inno:br/>explain how adjustments were<inno:br/>attributable to the pandemic and/or<inno:br/>were non-recurring.<inno:br/><inno:nec bbox="162.6 539.63 167.19 543.2" cid="1" code="0xf0b7" fid="21:0"/> CSA staff found a few instances<inno:br/>where the disclosure of NGMs was<inno:br/>potentially misleading as the issuer:<inno:br/>adjusted for expenses attributable to<inno:br/>COVID-19 without adjusting for<inno:br/>government subsidies or attempted to<inno:br/>“normalize” revenue or expenses for<inno:br/>the year-to-date period based on more<inno:br/>positive results for one quarter.</inno:font></inno:td>
<inno:td col="3" id="table-14-2-3" x-max="362.0" x-min="219.5" y-max="102.5" y-min="94.0"><inno:nec bbox="347.18 633.43 352.72 637.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Before presenting NGMs adjusted for COVID-</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-14-3-1" x-max="362.0" x-min="219.5" y-max="306.0" y-min="102.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">p g<inno:br/>19 impacts, consider how it assists investors,<inno:br/>how management uses the measure and why<inno:br/>management believes it is a useful and<inno:br/>meaningful alternative to explain the impact of<inno:br/>COVID-19.<inno:br/><inno:nec bbox="346.9 563.43 351.49 567.0" cid="1" code="0xf0b7" fid="21:0"/> Consider whether the adjustment matches the<inno:br/>corresponding usefulness of the NGM and the<inno:br/>disclosure is balanced (i.e., whether both<inno:br/>positive and negative components are<inno:br/>disclosed).<inno:br/><inno:nec bbox="347.18 505.03 352.72 508.6" cid="1" code="0xf0b7" fid="21:0"/> As the pandemic continues, there may be a<inno:br/>limited basis for management to conclude that<inno:br/>an adjustment is non-recurring, infrequent or<inno:br/>unusual even if the item is directly related to<inno:br/>COVID-19.<inno:br/><inno:nec bbox="347.18 446.53 352.72 450.1" cid="1" code="0xf0b7" fid="21:0"/> Be specific in describing adjustments (and not<inno:br/>simply disclose, for instance, “other costs<inno:br/>related to COVID”.<inno:br/><inno:nec bbox="347.18 411.23 352.72 414.8" cid="1" code="0xf0b7" fid="21:0"/> If disclosing NGMs adjusted for COVID-19,<inno:br/>include balanced adjustments and consider the<inno:br/>impacts of government subsidies, insurance<inno:br/>recoveries and relief from landlords.<inno:br/><inno:nec bbox="347.18 364.33 352.72 367.9" cid="1" code="0xf0b7" fid="21:0"/> All adjustments should be based on actual<inno:br/>results. Adjustments that attempt to estimate or<inno:br/>forecast results as if the pandemic had not<inno:br/>occurred are not appropriate.</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-14-4-1" x-max="99.0" x-min="45.0" y-max="315.5" y-min="306.0"/>
<inno:td col="2" id="table-14-4-2" x-max="219.5" x-min="99.0" y-max="315.5" y-min="306.0"/>
<inno:td col="3" id="table-14-4-3" x-max="362.0" x-min="219.5" y-max="315.5" y-min="306.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: SN 52-306</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-14-5-1" x-max="99.0" x-min="45.0" y-max="410.0" y-min="315.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">FLI in Effect<inno:br/>During COVID-<inno:br/>19</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-14-5-2" x-max="219.5" x-min="99.0" y-max="410.0" y-min="315.5"><inno:nec bbox="162.6 293.83 167.19 297.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Most issuers that disclosed financial<inno:br/>outlooks prior to COVID-19,<inno:br/>withdrew their FLI.<inno:br/><inno:nec bbox="162.6 258.43 167.19 262.0" cid="1" code="0xf0b7" fid="21:0"/> Some issuers provided detailed and<inno:br/>meaningful disclosure including<inno:br/>“outlook” sections with FLI<inno:br/>discussing the anticipated medium to<inno:br/>longer term impact of COVID-19 to<inno:br/>the issuer’s business and industry.<inno:br/><inno:nec bbox="162.6 188.43 167.19 192.0" cid="1" code="0xf0b7" fid="21:0"/> However, we also observed isolated<inno:br/>instances of insufficient disclosure of<inno:br/>assumptions and risks related to FLI</inno:font></inno:td>
<inno:td col="3" id="table-14-5-3" x-max="362.0" x-min="219.5" y-max="410.0" y-min="315.5"><inno:nec bbox="346.9 293.83 351.49 297.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">FLI can provide useful insight into how<inno:br/>management anticipates how COVID-19 will<inno:br/>impact the issuer’s future operations and liquidity<inno:br/>positions. However, the issuer must have a<inno:br/>reasonable basis for providing the FLI in the<inno:br/>current environment and provide sufficient<inno:br/>disclosure for investors to understand how the FLI<inno:br/>was derived and the related risks.<inno:br/><inno:nec bbox="346.9 200.73 351.49 204.3" cid="1" code="0xf0b7" fid="21:0"/> With rapidly changing circumstances, it is<inno:br/>essential that issuers update their MD&amp;A to<inno:br/>discuss the events or circumstances that are<inno:br/>reasonably likely to cause actual results to differ</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-86" type="text"><inno:block page="16" page-height="512" page-width="396" x-max="349.0" x-min="43.0" y-max="440.0" y-min="415.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">3</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">To improve the disclosure surrounding non-GAAP financial measures and certain other financial measures, the CSA is<inno:br/>intending to replace SN 52-306 with</inno:font> <inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt"><inno:u>Proposed National Instrument 52-112</inno:u></inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="9.00pt"><inno:i><inno:u>Non-GAAP and Other Financial Measures Disclosure</inno:u></inno:i></inno:font></inno:color><inno:br/><inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">and a related proposed Companion Policy (Proposed NI 52-112).</inno:font></inno:block></inno:text><inno:text id="text-87" type="text"><inno:block page="16" page-height="512" page-width="396" x-max="342.0" x-min="43.0" y-max="474.0" y-min="442.0"><inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">Proposed NI 52-112 sets out disclosure requirements for non-GAAP financial measures and other financial measures (e.g.,<inno:br/>segment measures, capital management measures, and supplementary financial measures as defined in Proposed NI 52-112). It<inno:br/>was published on September 6, 2018 for a first comment period and, after making revisions for comments received during the<inno:br/>first comment period, it was published on February 13, 2020 for a second comment period, which ended on June 29, 2020.</inno:font></inno:block></inno:text><inno:text id="text-88" type="text"><inno:block page="17" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="31.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-19-</inno:font></inno:block></inno:text><inno:table id="table-15" type="table"><inno:block page="17" page-height="512" page-width="396" x-max="364.0" x-min="45.0" y-max="480.0" y-min="42.0"><inno:tr row="1">
<inno:td col="1" id="table-15-1-1" x-max="98.0" x-min="45.0" y-max="53.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-15-1-2" x-max="219.5" x-min="98.0" y-max="53.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-15-1-3" x-max="364.0" x-min="219.5" y-max="53.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-15-2-1" x-max="98.0" x-min="45.0" y-max="98.5" y-min="53.5"/>
<inno:td col="2" id="table-15-2-2" x-max="219.5" x-min="98.0" y-max="98.5" y-min="53.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">and failure to update the MD&amp;A for<inno:br/>events that are likely to cause actual<inno:br/>results for future periods to differ<inno:br/>materially from previously disclosed<inno:br/>FLI</inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">.</inno:font></inno:td>
<inno:td col="3" id="table-15-2-3" x-max="364.0" x-min="219.5" y-max="98.5" y-min="53.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">from previously disclosed FLI.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider:</inno:font></inno:b><inno:br/><inno:nec bbox="346.9 663.33 351.49 666.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">If internal processes are in place to monitor and<inno:br/>update FLI as conditions change</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-15-3-1" x-max="98.0" x-min="45.0" y-max="129.0" y-min="98.5"/>
<inno:td col="2" id="table-15-3-2" x-max="219.5" x-min="98.0" y-max="129.0" y-min="98.5"/>
<inno:td col="3" id="table-15-3-3" x-max="364.0" x-min="219.5" y-max="129.0" y-min="98.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">References: Parts 4A, 4B and section 5.8 of NI<inno:br/>51-102; and Part 4A of Companion Policy 51-<inno:br/>102CP</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-15-4-1" x-max="98.0" x-min="45.0" y-max="352.0" y-min="129.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Material Change</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reporting</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-15-4-2" x-max="219.5" x-min="98.0" y-max="352.0" y-min="129.0"><inno:nec bbox="162.6 580.83 167.19 584.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Many issuers issued news releases in<inno:br/>relation to changes to their business,<inno:br/>operations or capital as a result of<inno:br/>COVID-19.<inno:br/><inno:nec bbox="162.6 533.93 167.19 537.5" cid="1" code="0xf0b7" fid="21:0"/> A few issuers filed material change<inno:br/>reports in relation to COVID-19<inno:br/>although in some instances changes to<inno:br/>the issuer’s business, operations or<inno:br/>capital were unique or more significant<inno:br/>to them than to others in their industry</inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">.</inno:font></inno:td>
<inno:td col="3" id="table-15-4-3" x-max="364.0" x-min="219.5" y-max="352.0" y-min="129.0"><inno:nec bbox="346.9 580.83 351.49 584.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The term “material change” is generally defined in<inno:br/>each jurisdiction’s securities legislation and is<inno:br/>usually based on a market impact test. Issuers<inno:br/>should refer to their principal regulator’s<inno:br/>applicable securities legislation for the definition<inno:br/>of “material change”.<inno:br/><inno:nec bbox="346.9 510.83 351.49 514.4" cid="1" code="0xf0b7" fid="21:0"/> If COVID-19 has an equal effect throughout an<inno:br/>issuer’s industry, a material change report may not<inno:br/>be required.<inno:br/><inno:nec bbox="346.9 475.53 351.49 479.1" cid="1" code="0xf0b7" fid="21:0"/> Issuers should be aware of the impact of COVID-<inno:br/>19, or resulting governmental or regulatory<inno:br/>policies, that may be unique or more significant to<inno:br/>them than to others in their industry as the<inno:br/>pandemic evolves.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Examples of potentially material information<inno:br/>includes:</inno:font></inno:b><inno:br/><inno:nec bbox="346.9 382.43 351.49 386.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Material changes in distributions or dividends<inno:br/><inno:nec bbox="346.9 370.13 351.49 373.7" cid="1" code="0xf0b7" fid="21:0"/> Changes in credit arrangements<inno:br/><inno:nec bbox="346.9 357.93 351.49 361.5" cid="1" code="0xf0b7" fid="21:0"/> Significant disruptions to an issuer’s workforce or<inno:br/>operations<inno:br/><inno:nec bbox="346.9 334.13 351.49 337.7" cid="1" code="0xf0b7" fid="21:0"/> Negative changes in markets, economy or laws<inno:br/><inno:nec bbox="346.9 321.83 351.49 325.4" cid="1" code="0xf0b7" fid="21:0"/> Supply chain delays or disruptions that are critical<inno:br/>to an issuer’s business<inno:br/><inno:nec bbox="346.9 298.03 351.49 301.6" cid="1" code="0xf0b7" fid="21:0"/> Increased cost of goods or services<inno:br/><inno:nec bbox="346.9 285.83 351.49 289.4" cid="1" code="0xf0b7" fid="21:0"/> Suspension of exports</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">References: Part 7 of NI 51-102, Form 51- 102F3</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Material Change Report</inno:i></inno:font><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">.</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-15-5-1" x-max="98.0" x-min="45.0" y-max="480.0" y-min="352.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Promotional<inno:br/>Disclosure</inno:font></inno:td>
<inno:td col="2" id="table-15-5-2" x-max="219.5" x-min="98.0" y-max="480.0" y-min="352.0"><inno:nec bbox="162.6 230.64 168.11 234.92" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers concentrated in the<inno:br/>biotech/pharma industry provided<inno:br/>disclosure in relation to COVID-19<inno:br/>that was overly promotional in nature<inno:br/>and often lacked specificity necessary<inno:br/>to enable a full understanding of the<inno:br/>issuer’s business intentions and<inno:br/>expected milestones.<inno:br/><inno:nec bbox="162.6 135.04 168.11 139.32" cid="1" code="0xf0b7" fid="21:0"/> In these instances, issuers filed<inno:br/>numerous press releases that either<inno:br/>overstated the positive impact on the<inno:br/>business of the issuer or were at such<inno:br/>an early stage that the true impact was<inno:br/>unknown and/or dependent upon too<inno:br/>many variables to realistically<inno:br/>determine if COVID-19 would</inno:font></inno:td>
<inno:td col="3" id="table-15-5-3" x-max="364.0" x-min="219.5" y-max="480.0" y-min="352.0"><inno:nec bbox="346.9 230.64 352.41 234.92" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers are prohibited from making false or<inno:br/>misleading statements or omitting facts from a<inno:br/>statement necessary to make that statement true<inno:br/>or not misleading.<inno:br/><inno:nec bbox="346.9 181.24 352.41 185.52" cid="1" code="0xf0b7" fid="21:0"/> Disclosure should be complete, balanced and<inno:br/>focused on material information. Both positive<inno:br/>and negative news should be given equal<inno:br/>prominence.<inno:br/><inno:nec bbox="346.9 131.94 352.41 136.22" cid="1" code="0xf0b7" fid="21:0"/> Establishing good disclosure practices can help<inno:br/>avoid the above situations. We recommend that<inno:br/>companies look to Part 6 of National Policy 51-<inno:br/>201</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="10.00pt"><inno:i>Disclosure Standards</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">to assist them in<inno:br/>setting up practices that assist them in<inno:br/>complying with the law and ensuring investors<inno:br/>have the best disclosure about their company in</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-89" type="text"><inno:block page="18" page-height="512" page-width="396" x-max="204.0" x-min="192.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-20-</inno:font></inno:block></inno:text><inno:table id="table-16" type="table"><inno:block page="18" page-height="512" page-width="396" x-max="362.0" x-min="45.0" y-max="103.0" y-min="42.0"><inno:tr row="1">
<inno:td col="1" id="table-16-1-1" x-max="100.0" x-min="45.0" y-max="52.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-16-1-2" x-max="216.0" x-min="100.0" y-max="52.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-16-1-3" x-max="362.0" x-min="216.0" y-max="52.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-16-2-1" x-max="100.0" x-min="45.0" y-max="67.5" y-min="52.5"/>
<inno:td col="2" id="table-16-2-2" rowspan="2" x-max="216.0" x-min="100.0" y-max="103.0" y-min="52.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">positively affect the issuer or its<inno:br/>business.<inno:br/><inno:nec bbox="162.6 673.14 168.11 677.42" cid="1" code="0xf0b7" fid="21:0"/> In one instance, an issuer failed to<inno:br/>disclose material facts that caused the<inno:br/>issuer to have a misrepresentation in<inno:br/>its public disclosure record.</inno:font></inno:td>
<inno:td col="3" id="table-16-2-3" x-max="362.0" x-min="216.0" y-max="67.5" y-min="52.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">a concise manner.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-16-3-1" x-max="100.0" x-min="45.0" y-max="103.0" y-min="67.5"/>
<inno:td col="2" id="table-16-3-2" x-max="362.0" x-min="216.0" y-max="103.0" y-min="67.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">References: National Policy 51-201</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="10.00pt"><inno:i>Disclosure<inno:br/>Standards</inno:i></inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">.</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-90" type="text"><inno:block page="18" page-height="512" page-width="396" x-max="201.0" x-min="45.0" y-max="477.0" y-min="462.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Appendix B – Disclosure Examples</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-91" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="202.0" x-min="192.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-21</inno:font></inno:block></inno:text><inno:text id="text-92" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="173.0" x-min="43.0" y-max="55.0" y-min="42.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="14.00pt">B.1 MD&amp;A Disclosure Examples</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-93" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="335.0" x-min="43.0" y-max="81.0" y-min="59.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Below are examples of useful disclosure focused on a few aspects of certain disclosure requirements.<inno:br/>Issuers should determine how specific securities requirements may apply to them.</inno:font></inno:block></inno:text><inno:text id="text-94" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="213.0" x-min="45.0" y-max="96.0" y-min="84.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.1.1 Discussion of Operations and the Impact of COVID-19</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-95" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="131.0" x-min="45.0" y-max="110.0" y-min="102.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Example of deficient disclosure</inno:font></inno:b></inno:block></inno:text><inno:text id="text-96" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="112.0" x-min="45.0" y-max="125.0" y-min="115.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.1(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-97" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="326.0" x-min="52.0" y-max="132.9" y-min="125.1"><inno:nec bbox="82.4 590.23 86.99 593.8" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not describe the specific operational factors contributing to the decline in revenue and expenses</inno:font></inno:block></inno:text><inno:text id="text-98" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="350.0" x-min="53.0" y-max="148.0" y-min="133.0"><inno:nec bbox="82.4 578.03 86.99 581.6" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not describe the judgements and estimations made by management in determining the impact of<inno:br/>COVID-19</inno:font></inno:block></inno:text><inno:text id="text-99" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="350.0" x-min="52.0" y-max="171.0" y-min="154.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Revenue decreased by 30% in Q3 2020 as compared to the prior period primarily due to the negative impact of<inno:br/>the COVID-19 pandemic.</inno:font></inno:block></inno:text><inno:text id="text-100" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="350.0" x-min="52.0" y-max="194.0" y-min="178.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Selling, general and administrative expenses decreased by $5M in Q3, 2020 due to management’s efforts to<inno:br/>reduce costs due to COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-101" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="136.0" x-min="45.0" y-max="225.0" y-min="217.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-102" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="111.0" x-min="45.0" y-max="240.0" y-min="230.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.1(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-103" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="210.0" x-min="52.0" y-max="249.0" y-min="240.1"><inno:nec bbox="82.7 412.33 87.29 415.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provides an entity-specific analysis to explain variances</inno:font></inno:block></inno:text><inno:text id="text-104" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="246.0" x-min="52.0" y-max="256.0" y-min="249.1"><inno:nec bbox="82.7 400.03 87.29 403.6" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Describes the methodology used to estimate the impact of COVID-19</inno:font></inno:block></inno:text><inno:text id="text-105" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="342.0" x-min="45.0" y-max="294.0" y-min="263.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">As described above, we shut down 25 locations country-wide in mid-September, and these locations remain<inno:br/>closed as at the date of this MD&amp;A. 14 locations remained open during the quarter for take-out only. In order<inno:br/>to mitigate the impacts of store closures and reduced revenues, we have temporarily laid off certain staff. Our<inno:br/>mitigating efforts are described in further detail in the Recent Developments section.</inno:font></inno:block></inno:text><inno:text id="text-106" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="342.0" x-min="52.0" y-max="355.0" y-min="300.0"><inno:nec bbox="83.2 317.53 87.79 321.1" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Revenue decreased by 30% from Q3, 2019 due to an estimated loss of sales of $7M from restaurants<inno:br/>negatively affected by COVID-19. The closures noted above were in effect for 2 weeks during the<inno:br/>reporting period. Based on our estimate for each location, the loss in revenues due to store closures was<inno:br/>approximately $3M for Q3, 2020 (based on a 2-week average sales at those stores in prior periods). A<inno:br/>further reduction of revenue of $4M is estimated from locations that remained open as take-out only or<inno:br/>were subject to reduced capacity limits for Q3, 2020 due to a reduction in revenue/hour from the loss of<inno:br/>customers dining in and shorter operating times.</inno:font></inno:block></inno:text><inno:text id="text-107" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="295.0" x-min="52.0" y-max="370.0" y-min="361.0"><inno:nec bbox="83.2 224.43 87.79 228.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Selling, general and administrative (SG&amp;A) expenses decreased by $5M from Q3, 2019:</inno:font></inno:block></inno:text><inno:text id="text-108" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="342.0" x-min="64.0" y-max="393.0" y-min="376.0"><inno:nec bbox="101.2 200.63 105.79 204.2" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The decrease reflects an estimated $2M in rent savings and a decrease in $2M of wages based on<inno:br/>management’s calculation of the impact of location closures and reduced capacity limits.</inno:font></inno:block></inno:text><inno:text id="text-109" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="342.0" x-min="63.0" y-max="423.0" y-min="399.0"><inno:nec bbox="101.2 165.33 105.79 168.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">In Q3 2020, the Company also benefitted from $1.5M due to the Canadian Emergency Wage Subsidy<inno:br/>Program, of which $1M was recorded as a reduction to SG&amp;A expenses, and $500K as a reduction to<inno:br/>cost of sales which allows the Company to maintain a comparable gross margin to the prior period.</inno:font></inno:block></inno:text><inno:text id="text-110" type="text"><inno:block page="19" page-height="512" page-width="396" x-max="246.0" x-min="45.0" y-max="476.0" y-min="465.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.1.2 Discussion of Measures Taken to Reduce the Impact of COVID-19</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-111" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-22-</inno:font></inno:block></inno:text><inno:text id="text-112" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="132.0" x-min="45.0" y-max="52.0" y-min="43.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of deficient disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-113" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="107.0" x-min="45.0" y-max="67.0" y-min="57.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.2(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-114" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="270.0" x-min="45.0" y-max="76.0" y-min="67.1"><inno:nec bbox="75.4 679.83 79.99 683.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not explain the impact of measures taken to reduce the impact of COVID-19</inno:font></inno:block></inno:text><inno:text id="text-115" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="341.0" x-min="45.0" y-max="121.0" y-min="83.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company has implemented a series of cost reduction measures in response to COVID-19. These measures<inno:br/>include the following: suspension of the quarterly dividend, reduced compensation, reduction of discretionary<inno:br/>spending, delayed capital projects, sales of assets and taking advantage of the Canadian Emergency Wage<inno:br/>Subsidy Program. The Company is monitoring the situation and will adjust these measures as the situation<inno:br/>evolves.</inno:font></inno:block></inno:text><inno:text id="text-116" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="135.0" x-min="45.0" y-max="151.0" y-min="141.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-117" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="107.0" x-min="45.0" y-max="167.0" y-min="157.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.2(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-118" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="212.0" x-min="45.0" y-max="175.0" y-min="167.1"><inno:nec bbox="75.7 526.13 80.29 529.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Discussed specific measures taken and effect on the issuer</inno:font></inno:block></inno:text><inno:text id="text-119" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="213.0" y-min="182.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company has implemented several operational responses to address the reduced current demand and the high<inno:br/>degree of uncertainty in future sales. These strategies include an estimated annual reduction of $25M in expenses,<inno:br/>a reduction of capital spending and generating $10M in cash from non-core asset sales. The Company has<inno:br/>completed the following actions to reduce costs and meet its stated targets as at September 30, 2020:</inno:font></inno:block></inno:text><inno:text id="text-120" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="338.0" x-min="45.0" y-max="234.0" y-min="219.0"><inno:nec bbox="75.7 444.13 80.29 447.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Suspension of the quarterly dividend commencing in Q2, 2020 (anticipated to remain in effect until at least<inno:br/>Q2 2021).</inno:font></inno:block></inno:text><inno:text id="text-121" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="325.0" x-min="45.0" y-max="258.0" y-min="242.0"><inno:nec bbox="75.7 408.83 80.29 412.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Reduced Board of Director compensation by 40% and executive compensation by 25% resulting in an<inno:br/>estimated reduction in compensation costs of $3M for fiscal 2020.</inno:font></inno:block></inno:text><inno:text id="text-122" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="335.0" x-min="45.0" y-max="281.0" y-min="265.0"><inno:nec bbox="75.7 373.43 80.29 377.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Elimination of all non-essential travel, entertainment and other discretionary spending estimated to reduce<inno:br/>annual costs by $8M</inno:font></inno:block></inno:text><inno:text id="text-123" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="333.0" x-min="45.0" y-max="302.0" y-min="287.0"><inno:nec bbox="75.7 338.13 80.29 341.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Reduction of purchases of property, plant and equipment to approximately $30.0 million over the next 12<inno:br/>months</inno:font></inno:block></inno:text><inno:text id="text-124" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="326.0" y-min="310.0"><inno:nec bbox="75.7 302.73 80.29 306.3" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Sales of non-core assets of $5M in Q3, 2020 with additional sales of non-core assets of $5M anticipated to be<inno:br/>completed in Q4, 2020.</inno:font></inno:block></inno:text><inno:text id="text-125" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="357.0" y-min="333.0"><inno:nec bbox="75.7 267.43 80.29 271.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Taking advantage of the Canadian Emergency Wage Subsidy Program (CEWS) to help offset the reduction in<inno:br/>revenues. The Company realized $6M under this program for Q3, 2020 which is recorded as a reduction in<inno:br/>SG&amp;A expenses. The Company expects it will continue to qualify for this program for the balance of 2020.</inno:font></inno:block></inno:text><inno:text id="text-126" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="152.0" x-min="45.0" y-max="403.0" y-min="393.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.1.3 Liquidity and Capital Resources</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-127" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="139.0" x-min="45.0" y-max="418.0" y-min="409.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of boilerplate disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-128" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="111.0" x-min="52.0" y-max="433.0" y-min="423.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.3(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-129" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="272.0" x-min="53.0" y-max="442.0" y-min="433.1"><inno:nec bbox="82.5 113.33 87.09 116.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not discuss covenant terms or provide for an understanding of liquidity risk</inno:font></inno:block></inno:text><inno:text id="text-130" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="342.0" x-min="45.0" y-max="471.9" y-min="448.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company is currently in compliance with the financial covenants under its credit facility. The Company<inno:br/>expects that the COVID-19 pandemic may impact covenant compliance in future periods and has entered into<inno:br/>an amending agreement with lenders and will be subject to revised measures for Q4 2020.</inno:font></inno:block></inno:text><inno:text id="text-131" type="text"><inno:block page="20" page-height="512" page-width="396" x-max="137.0" x-min="45.0" y-max="480.0" y-min="472.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-132" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="203.0" x-min="192.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-23-</inno:font></inno:block></inno:text><inno:text id="text-133" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="107.0" x-min="45.0" y-max="52.0" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.3(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-134" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="67.0" y-min="52.1"><inno:nec bbox="75.7 703.43 80.29 707.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provided quantitative and qualitative disclosure to understand compliance with financial covenants and<inno:br/>related liquidity risk</inno:font></inno:block></inno:text><inno:text id="text-135" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="97.0" y-min="75.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company’s lending agreements require the Company to comply with the following covenants: maximum<inno:br/>leverage ratio of 4.5 and minimum interest coverage ratio of 2.75. Calculation of financial covenants for Q3 2020<inno:br/>is as follows:</inno:font></inno:block></inno:text><inno:table id="table-17" type="table"><inno:block page="21" page-height="512" page-width="396" x-max="304.0" x-min="61.0" y-max="154.0" y-min="110.0"><inno:tr row="1">
<inno:td col="1" id="table-17-1-1" x-max="142.0" x-min="61.0" y-max="123.5" y-min="110.0"/>
<inno:td col="2" id="table-17-1-2" x-max="230.0" x-min="142.0" y-max="123.5" y-min="110.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>September 30, 2020</inno:u></inno:font></inno:td>
<inno:td col="3" id="table-17-1-3" x-max="304.0" x-min="230.0" y-max="123.5" y-min="110.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>September 30, 2019</inno:u></inno:font></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-17-2-1" x-max="142.0" x-min="61.0" y-max="139.0" y-min="123.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Interest Coverage Ratio</inno:font></inno:td>
<inno:td col="2" id="table-17-2-2" x-max="230.0" x-min="142.0" y-max="139.0" y-min="123.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">3.0</inno:font></inno:td>
<inno:td col="3" id="table-17-2-3" x-max="304.0" x-min="230.0" y-max="139.0" y-min="123.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">5.0</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-17-3-1" x-max="142.0" x-min="61.0" y-max="154.0" y-min="139.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Total Leverage Ratio</inno:font></inno:td>
<inno:td col="2" id="table-17-3-2" x-max="230.0" x-min="142.0" y-max="154.0" y-min="139.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">4.0</inno:font></inno:td>
<inno:td col="3" id="table-17-3-3" x-max="304.0" x-min="230.0" y-max="154.0" y-min="139.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">3.0</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-136" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="219.0" y-min="164.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company now expects that the combination of lower expected EBITDA in 2020 combined with the<inno:br/>Company’s current debt profile and the ongoing uncertainty created by the COVID-19 pandemic, may impact<inno:br/>compliance with the total leverage ratio and interest coverage covenants at December 31, 2020. Management has<inno:br/>been negotiating with its syndicate of lenders and has entered into an amended agreement under its credit facility.<inno:br/>Under the amended agreement, the Company is subject to a maximum leverage ratio of 5.5 and minimum interest<inno:br/>coverage ratio of 2.5 from Q4, 2020 to Q2, 2021. The Company has incurred fees and expenses of $1 million to<inno:br/>date to implement these amendments and expects to incur another $0.5 million in Q4 2020.</inno:font></inno:block></inno:text><inno:text id="text-137" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="125.0" x-min="45.0" y-max="249.0" y-min="239.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.1.4 Risk Factor Disclosure</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-138" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="132.0" x-min="45.0" y-max="264.0" y-min="255.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of deficient disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-139" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="107.0" x-min="45.0" y-max="280.0" y-min="269.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.4(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-140" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="301.0" x-min="45.0" y-max="288.0" y-min="280.1"><inno:nec bbox="75.7 351.63 80.29 355.2" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Disclosure was generic and did not provide any information on the risks specific to the issuer</inno:font></inno:block></inno:text><inno:text id="text-141" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="340.0" y-min="295.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic.<inno:br/>Governments have imposed measures to contain the outbreak, including business closures, travel restrictions,<inno:br/>quarantines and social distancing measures. The spread of the COVID-19 virus has resulted in a sharp decline in<inno:br/>global economic growth as well as causing increased volatility in financial markets. If the COVID-19 pandemic<inno:br/>is prolonged, the adverse impact on the global economy could worsen. Accordingly, the full impact of the<inno:br/>COVID-19 is uncertain and may have a material adverse effect on the Company.</inno:font></inno:block></inno:text><inno:text id="text-142" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="137.0" x-min="45.0" y-max="378.0" y-min="368.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Examples of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-143" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="107.0" x-min="45.0" y-max="394.0" y-min="384.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.1.4(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-144" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="227.0" x-min="45.0" y-max="402.0" y-min="394.1"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provided entity-specific disclosure of risks and impacts to the issuer</inno:font></inno:block></inno:text><inno:text id="text-145" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="422.0" y-min="406.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Based on events and circumstances known to us to date, we believe that the Company may be subject the<inno:br/>following risks beyond Q3 2020:</inno:font></inno:block></inno:text><inno:text id="text-146" type="text"><inno:block page="21" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="468.0" y-min="430.0"><inno:nec bbox="77.8 119.33 82.39 122.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Consumer demand will continue to be the Company’s most significant risk due to the uncertainty in the<inno:br/>global economy, negatively impacting our retail stores. Many of our stores are located in areas that<inno:br/>historically have had higher densities of tourism and will experience a greater negative impact and slower<inno:br/>recovery than perhaps other retailers. While eCommerce sales have increased, we expect to continue to incur<inno:br/>significant sales losses as overall customer demand and consumer spending is expected to continue to</inno:font></inno:block></inno:text><inno:text id="text-147" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="202.0" x-min="192.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-24</inno:font></inno:block></inno:text><inno:text id="text-148" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="327.0" x-min="60.0" y-max="52.0" y-min="42.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">decline, as compared to prior year, in response to COVID-19 and the related global economic impacts.</inno:font></inno:block></inno:text><inno:text id="text-149" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="350.0" x-min="43.0" y-max="96.0" y-min="59.0"><inno:nec bbox="77.8 692.33 82.39 695.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Social distancing restrictions to protect the safety of our customers and employees may limit both the number<inno:br/>of customers we can serve at our retail stores, and the volume of goods we are able to fulfill through our<inno:br/>distribution centre. More severe government-imposed restrictions, including store capacity restrictions and<inno:br/>lockdowns, could further restrict our ability to service our customers. See also “Subsequent Events” for<inno:br/>further discussion on store closures in relation to COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-150" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="350.0" x-min="43.0" y-max="127.0" y-min="104.0"><inno:nec bbox="77.8 622.33 82.39 625.9" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">We may also face supply chain challenges if there are disruptions in service at our distribution centre,<inno:br/>suppliers, or logistics providers. Increased market demand for logistic providers may continue to increase our<inno:br/>operating costs and/or limit our ability to fulfill sales.</inno:font></inno:block></inno:text><inno:text id="text-151" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="350.0" x-min="43.0" y-max="157.0" y-min="134.0"><inno:nec bbox="77.8 575.43 82.39 579.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The costs of operating our stores and distribution centre may continue to increase due to enhanced health and<inno:br/>safety measures taken to protect our employees, including the increased costs of personal protective<inno:br/>equipment.</inno:font></inno:block></inno:text><inno:text id="text-152" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="350.0" x-min="43.0" y-max="181.0" y-min="164.0"><inno:nec bbox="77.8 528.53 82.39 532.1" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Access to government financial assistance programs may place restrictions on our business and operations,<inno:br/>including our ability to deploy capital or return capital to our shareholders.</inno:font></inno:block></inno:text><inno:text id="text-153" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="350.0" x-min="43.0" y-max="211.0" y-min="187.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">While the full-extent of the impact of COVID-19 on the Company’s business remains uncertain, we believe that<inno:br/>the cost reductions and liquidity management strategies employed will partially mitigate the above risks as further<inno:br/>described under “Recent Developments”.</inno:font></inno:block></inno:text><inno:text id="text-154" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="184.0" x-min="43.0" y-max="244.0" y-min="232.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="14.00pt">B.2 Financial Statements Examples</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-155" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="334.0" x-min="43.0" y-max="269.0" y-min="249.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Below are examples of useful disclosure focused on a few aspects of certain IFRS requirements. Issuers should<inno:br/>determine how specific IFRS requirements may apply to them.</inno:font></inno:block></inno:text><inno:text id="text-156" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="162.0" x-min="43.0" y-max="283.0" y-min="273.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.2.1 Impairment of Non-Financial Assets</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-157" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="133.0" x-min="43.0" y-max="298.0" y-min="290.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of deficient disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-158" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="106.0" x-min="43.0" y-max="314.0" y-min="304.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.2.1(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-159" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="166.0" x-min="43.0" y-max="322.0" y-min="314.1"><inno:nec bbox="77.8 297.93 82.39 301.5" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not identify reasons for impairments</inno:font></inno:block></inno:text><inno:text id="text-160" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="270.0" x-min="43.0" y-max="331.0" y-min="322.1"><inno:nec bbox="77.8 285.63 82.39 289.2" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not disclose the key assumptions used in estimating the recoverable amount</inno:font></inno:block></inno:text><inno:text id="text-161" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="332.0" x-min="43.0" y-max="354.0" y-min="337.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company recognized for the quarter ended September 30, 2020, costs related to the write‐down of assets<inno:br/>totalling $XXX mainly due to the impairment of PP&amp;E.</inno:font></inno:block></inno:text><inno:text id="text-162" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="135.0" x-min="43.0" y-max="376.0" y-min="366.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-163" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="107.0" x-min="43.0" y-max="391.0" y-min="381.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.2.1(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-164" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="340.0" x-min="43.0" y-max="408.0" y-min="393.0"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Identified impairment indicators as the government-imposed closures and significant decrease in the issuer’s<inno:br/>market capitalization</inno:font></inno:block></inno:text><inno:text id="text-165" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="335.0" x-min="43.0" y-max="424.0" y-min="408.1"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Adequately disclosed supportable assumptions used to determine fair value less costs of disposal with the<inno:br/>implications of COVID-19</inno:font></inno:block></inno:text><inno:text id="text-166" type="text"><inno:block page="22" page-height="512" page-width="396" x-max="343.0" x-min="43.0" y-max="471.0" y-min="425.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The majority of the Company’s operations in segment XYZ were closed, and currently remain closed or are<inno:br/>operating at a reduced occupancy as a result of mandatory closure orders from various government authorities. In<inno:br/>light of this temporary closure and a material decrease in the Company’s market value due to a sharp decline in<inno:br/>its share price, the Company concluded that this segment, which is a cash generating unit (“CGU”), should be<inno:br/>tested for impairment at period end. The Company did not identify any further indicators of impairment or<inno:br/>impairment reversals for its other CGU's.</inno:font></inno:block></inno:text><inno:text id="text-167" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="203.0" x-min="191.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-25-</inno:font></inno:block></inno:text><inno:text id="text-168" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="112.0" y-min="42.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The recoverable amount for the CGU has been estimated using a discounted cash flow (value in use) model. The<inno:br/>Company calculates value in use using a five-year discounted cash flow method based on the most recent<inno:br/>financial budget forecasts approved by management. The future cash flows are based on a range of<inno:br/>estimates and assumptions, including growth in average sales from XX% to XX% for the period 2020-202X to<inno:br/>reflect a staged reopening and other scenarios and a pre-tax discount rate of XX% (which represents the weighted<inno:br/>average cost of capital). For the nine months ended September 30, 2020, the Company recorded a total<inno:br/>impairment charge of $XXX million relating to the entire goodwill balance allocated to this CGU of $XX million<inno:br/>and an impairment on the PP&amp;E in this CGU of $XXX million. The recoverable amount of the Company’s<inno:br/>impaired CGU at September 30, 2020 was $XXX million.</inno:font></inno:block></inno:text><inno:text id="text-169" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="338.0" x-min="45.0" y-max="142.0" y-min="118.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company conducts sensitivity analyses by varying the pre-tax discount rate upward by X% and the growth<inno:br/>rates down by X%. Such sensitivity analyses demonstrate that a reasonable change in assumptions would not<inno:br/>result in the CGU’s carrying value exceeding its value in use.</inno:font></inno:block></inno:text><inno:text id="text-170" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="104.0" x-min="45.0" y-max="156.0" y-min="147.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.2.2 Going Concern</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-171" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="131.0" x-min="45.0" y-max="171.0" y-min="163.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Example of deficient disclosure</inno:font></inno:b></inno:block></inno:text><inno:text id="text-172" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="107.0" x-min="45.0" y-max="186.0" y-min="177.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.2.2(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-173" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="342.0" x-min="45.0" y-max="203.9" y-min="188.0"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not provide entity-specific disclosure in connection with the issuer’s financial condition considering the<inno:br/>impact of COVID-19 outbreak</inno:font></inno:block></inno:text><inno:text id="text-174" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="243.0" y-min="204.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">As at September 30, 2020, the Company is not able to finance day to day activities through operations. The<inno:br/>continued operations of the Company are dependent on future profitable operations, management’s ability to<inno:br/>manage costs, and the future availability of equity or debt financing. Whether and when the Company can<inno:br/>generate sufficient operating cash flows to pay for its expenditures and settle its obligations as they fall due is<inno:br/>uncertain.</inno:font></inno:block></inno:text><inno:text id="text-175" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="136.0" x-min="45.0" y-max="273.0" y-min="263.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-176" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="106.0" x-min="45.0" y-max="288.0" y-min="278.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.2.2(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-177" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="338.0" x-min="45.0" y-max="313.0" y-min="289.0"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Included disclosure indicating there was a “close call” situation where significant judgement was applied in<inno:br/>concluding there were no material uncertainties that might cast significant doubt on the Issuer’s ability to<inno:br/>continue as a going concern</inno:font></inno:block></inno:text><inno:text id="text-178" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="301.0" x-min="45.0" y-max="323.0" y-min="314.0"><inno:b><inno:font font-name="Calibri-Bold" font-size="12.00pt">•</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Disclosed factors used in the decision to conclude the Issuer will continue as a going concern</inno:font></inno:block></inno:text><inno:text id="text-179" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="368.0" y-min="330.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The spread of COVID-19 in all relevant jurisdictions has impacted the Company’s supply chain and consumer<inno:br/>base and uncertainty regarding the extent, duration and severity of business disruptions are having a material<inno:br/>impact on all aspects of the Company’s operations. Currently, the Company is not generating sufficient funds<inno:br/>from operations to support its day-to-day activities. These conditions call into question the Company’s ability to<inno:br/>continue as a going concern.</inno:font></inno:block></inno:text><inno:text id="text-180" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="390.0" y-min="375.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">In response to the uncertainty caused by the COVID-19 global pandemic, the Company has taken or plans to take<inno:br/>several actions including:</inno:font></inno:block></inno:text><inno:text id="text-181" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="332.0" x-min="61.0" y-max="397.9" y-min="391.0"><inno:nec bbox="95.8 179.63 100.39 183.2" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">announced that it will not be paying dividends in the foreseeable future until conditions improve</inno:font></inno:block></inno:text><inno:text id="text-182" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="59.0" y-max="412.9" y-min="398.0"><inno:nec bbox="95.8 167.43 100.39 171.0" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">actively monitoring cash flow forecasts and results, which has resulted in significant cost savings in the<inno:br/>short-term</inno:font></inno:block></inno:text><inno:text id="text-183" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="60.0" y-max="429.9" y-min="413.0"><inno:nec bbox="95.8 143.63 100.39 147.2" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">subsequent to period end, the Company successfully negotiated an increase to its credit facility that<inno:br/>included revised covenants</inno:font></inno:block></inno:text><inno:text id="text-184" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="53.0" y-max="446.0" y-min="430.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">ased on these actions, its diversified business and current backlog, the Company expects to generate sufficient</inno:font></inno:block></inno:text><inno:text id="text-185" type="text"><inno:block page="23" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="475.0" y-min="459.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">As a result, after considering all relevant information, including its actions completed to date and its future plans,<inno:br/>management has concluded that there are no material uncertainties related to events or conditions that may cast</inno:font></inno:block></inno:text><inno:text id="text-186" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="203.0" x-min="191.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-26-</inno:font></inno:block></inno:text><inno:text id="text-187" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="59.0" y-min="42.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">significant doubt upon the Company’s ability to continue as a going concern for a period of 12 months from the<inno:br/>consolidated balance sheet date.</inno:font></inno:block></inno:text><inno:text id="text-188" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="97.0" y-min="66.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The estimates used by management in reaching this conclusion are based on information available as of the date<inno:br/>these financial statements were authorized for issuance and include internally generated cash flow forecasts.<inno:br/>Accordingly, actual results could differ from these estimates and resulting variances may be material to<inno:br/>management’s assessment.</inno:font></inno:block></inno:text><inno:text id="text-189" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="127.0" x-min="45.0" y-max="122.0" y-min="112.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.2.3 Government Assistance</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-190" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="131.0" x-min="45.0" y-max="136.0" y-min="128.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Example of deficient disclosure</inno:font></inno:b></inno:block></inno:text><inno:text id="text-191" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="106.0" x-min="45.0" y-max="154.0" y-min="142.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.2.3(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-192" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="341.0" x-min="45.0" y-max="175.0" y-min="160.0"><inno:nec bbox="77.8 536.13 82.39 539.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The accounting policy adopted for government grants, including the methods of presentation adopted in the<inno:br/>financial statements</inno:font></inno:block></inno:text><inno:text id="text-193" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="273.0" x-min="45.0" y-max="184.0" y-min="176.0"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The nature and extent of government grants recognized in the financial statements</inno:font></inno:block></inno:text><inno:text id="text-194" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="339.0" x-min="45.0" y-max="195.0" y-min="186.0"><inno:b><inno:font font-name="Calibri-Bold" font-size="12.00pt">•</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Unfulfilled conditions and other contingencies attaching to government assistance that has been recognized</inno:font></inno:block></inno:text><inno:text id="text-195" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="232.0" y-min="202.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Canada Emergency Wage Subsidy (“CEWS”) was put in place by government of Canada to provide a wage<inno:br/>subsidy to eligible employers to help get Canadians hired back quickly as provincial and territorial economies<inno:br/>began to reopen. The Company recognized $XXX and $XXX of CEWS during the three and six months ended<inno:br/>Q3 2020 as subsidy.</inno:font></inno:block></inno:text><inno:text id="text-196" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="136.0" x-min="45.0" y-max="255.0" y-min="245.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-197" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="107.0" x-min="45.0" y-max="271.0" y-min="261.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.2.3(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-198" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="189.0" x-min="45.0" y-max="280.0" y-min="271.1"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provided all the required disclosure under IAS 20</inno:font></inno:block></inno:text><inno:text id="text-199" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="318.0" y-min="288.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">In response to the negative economic impact of COVID-19, the Government of Canada announced the Canada<inno:br/>Emergency Wage Subsidy (“CEWS”) program in April 2020, retroactive to March 15, 2020. CEWS provides a<inno:br/>wage subsidy to eligible employers based on certain criteria, including demonstration of revenue declines as<inno:br/>result of COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-200" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="356.0" y-min="325.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company has determined that it has qualified for this subsidy from March 15, 2020 through September 30,<inno:br/>2020 and has, accordingly, applied for, and for certain periods received, the CEWS. The Company also intends to<inno:br/>apply for the CEWS in subsequent application periods it is available, subject to continuing to meet the applicable<inno:br/>qualification criteria.</inno:font></inno:block></inno:text><inno:text id="text-201" type="text"><inno:block page="24" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="394.0" y-min="363.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">For the three and nine month ended September 30, 2020, the Company has recognized $XXX and $XXX from<inno:br/>the CEWS program, respectively, and has recorded it as a reduction to the eligible remuneration expense in<inno:br/>selling, general and administrative expenses. As of September 30, 2020, the Company has received $XXX from<inno:br/>the CEWS program and expects to receive the remaining recognized subsidy in the following fiscal quarter.</inno:font></inno:block></inno:text><inno:text id="text-202" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="203.0" x-min="191.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-27-</inno:font></inno:block></inno:text><inno:text id="text-203" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="204.0" x-min="43.0" y-max="57.0" y-min="42.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="14.00pt">B.3 Other Regulatory Matters Examples</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-204" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="338.0" x-min="43.0" y-max="79.0" y-min="59.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Below is an example that focuses on certain disclosure requirements relating to NGMs. Issuers should<inno:br/>determine how specific securities requirements may apply to them.</inno:font></inno:block></inno:text><inno:text id="text-205" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="149.0" x-min="45.0" y-max="95.0" y-min="84.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">B.3.1 Non-GAAP Financial Measures</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-206" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="131.0" x-min="45.0" y-max="109.0" y-min="101.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Example of deficient disclosure</inno:font></inno:b></inno:block></inno:text><inno:text id="text-207" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="106.0" x-min="45.0" y-max="125.0" y-min="115.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.3.1(a)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-208" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="294.0" x-min="45.0" y-max="134.9" y-min="126.0"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not explain how increased costs are related to COVID-19 and the nature of such costs</inno:font></inno:block></inno:text><inno:text id="text-209" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="152.0" y-min="135.0"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Did not explain why this measure provides useful information to investors and the additional purposes, if any,<inno:br/>management uses the NGM.</inno:font></inno:block></inno:text><inno:text id="text-210" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="320.0" x-min="45.0" y-max="168.0" y-min="152.1"><inno:font font-name="Calibri" font-size="12.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">In this case, the Company also benefitted from government assistance which was not included as an<inno:br/>adjustment, making the measure potentially misleading</inno:font></inno:block></inno:text><inno:text id="text-211" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="118.0" x-min="45.0" y-max="177.0" y-min="169.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">NGMs in a News Release</inno:font></inno:block></inno:text><inno:text id="text-212" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="343.0" x-min="45.0" y-max="192.0" y-min="181.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">COMPANY ABC REPORTS NET EARNINGS OF $5 MILLION AND ADJUSTED EBITDA OF $14 M</inno:font></inno:b></inno:block></inno:text><inno:text id="text-213" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="257.0" x-min="45.0" y-max="207.9" y-min="197.0"><inno:nec bbox="77.8 475.13 82.39 478.7" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Net Earnings decreased 58% from the same period in the prior year to $5M</inno:font></inno:block></inno:text><inno:text id="text-214" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="276.0" x-min="45.0" y-max="217.0" y-min="208.0"><inno:nec bbox="77.8 462.83 82.39 466.4" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Adjusted EBITDA decreased 12% from the same period in the prior year to $14M.</inno:font></inno:block></inno:text><inno:text id="text-215" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="253.0" y-min="223.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">*Adjusted EBITDA is a non-GAAP financial measure that is adjusted to exclude amounts that are outside the<inno:br/>Company’s normal activities. For more information, refer to the section on Non-GAAP Financial Measures at the<inno:br/>end of this news release, and below for a reconciliation of adjusted EBITDA to the most comparable GAAP<inno:br/>measure.</inno:font></inno:block></inno:text><inno:table id="table-18" type="table"><inno:block page="25" page-height="512" page-width="396" x-max="245.0" x-min="45.0" y-max="390.0" y-min="273.0"><inno:tr row="1">
<inno:td col="1" id="table-18-1-1" x-max="159.0" x-min="45.0" y-max="289.5" y-min="273.0"/>
<inno:td col="2" id="table-18-1-2" x-max="200.5" x-min="159.0" y-max="289.5" y-min="273.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>XX, 2020</inno:u></inno:font></inno:td>
<inno:td col="3" id="table-18-1-3" x-max="245.0" x-min="200.5" y-max="289.5" y-min="273.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>XX, 2019</inno:u></inno:font></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-18-2-1" x-max="159.0" x-min="45.0" y-max="307.5" y-min="289.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Net earnings</inno:font></inno:td>
<inno:td col="2" id="table-18-2-2" x-max="200.5" x-min="159.0" y-max="307.5" y-min="289.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$5M</inno:font></inno:td>
<inno:td col="3" id="table-18-2-3" x-max="245.0" x-min="200.5" y-max="307.5" y-min="289.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$12M</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-18-3-1" x-max="159.0" x-min="45.0" y-max="323.0" y-min="307.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Interest</inno:font></inno:td>
<inno:td col="2" id="table-18-3-2" x-max="200.5" x-min="159.0" y-max="323.0" y-min="307.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$2M</inno:font></inno:td>
<inno:td col="3" id="table-18-3-3" x-max="245.0" x-min="200.5" y-max="323.0" y-min="307.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$1M</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-18-4-1" x-max="159.0" x-min="45.0" y-max="339.0" y-min="323.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Depreciation</inno:font></inno:td>
<inno:td col="2" id="table-18-4-2" x-max="200.5" x-min="159.0" y-max="339.0" y-min="323.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>$3M</inno:u></inno:font></inno:td>
<inno:td col="3" id="table-18-4-3" x-max="245.0" x-min="200.5" y-max="339.0" y-min="323.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>$3M</inno:u></inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-18-5-1" x-max="159.0" x-min="45.0" y-max="354.0" y-min="339.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">EBITDA</inno:font></inno:td>
<inno:td col="2" id="table-18-5-2" x-max="200.5" x-min="159.0" y-max="354.0" y-min="339.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$10M</inno:font></inno:td>
<inno:td col="3" id="table-18-5-3" x-max="245.0" x-min="200.5" y-max="354.0" y-min="339.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$16M</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-18-6-1" x-max="159.0" x-min="45.0" y-max="370.5" y-min="354.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Increased costs due to COVID-19 (1)</inno:font></inno:td>
<inno:td col="2" id="table-18-6-2" x-max="200.5" x-min="159.0" y-max="370.5" y-min="354.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>$4M</inno:u></inno:font></inno:td>
<inno:td col="3" id="table-18-6-3" x-max="245.0" x-min="200.5" y-max="370.5" y-min="354.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">-</inno:font></inno:td>
</inno:tr>
<inno:tr row="7">
<inno:td col="1" id="table-18-7-1" x-max="159.0" x-min="45.0" y-max="390.0" y-min="370.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">ADJUSTED EBITDA</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-18-7-2" x-max="200.5" x-min="159.0" y-max="390.0" y-min="370.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">$14M</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-18-7-3" x-max="245.0" x-min="200.5" y-max="390.0" y-min="370.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">$16M</inno:font></inno:b></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-216" type="text"><inno:block page="25" page-height="512" page-width="396" x-max="180.0" x-min="45.0" y-max="411.0" y-min="403.0"><inno:font font-name="TimesNewRomanPSMT" font-size="8.50pt">1. The increased costs are due to the COVID-19 pandemic.</inno:font></inno:block></inno:text><inno:text id="text-217" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="204.0" x-min="191.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-28-</inno:font></inno:block></inno:text><inno:text id="text-218" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="135.0" x-min="45.0" y-max="61.0" y-min="52.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt"><inno:u>Example of improved disclosure</inno:u></inno:font></inno:b></inno:block></inno:text><inno:text id="text-219" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="106.0" x-min="45.0" y-max="75.0" y-min="66.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">EXAMPLE B.3.1(b)</inno:font></inno:b></inno:block></inno:text><inno:text id="text-220" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="234.0" x-min="45.0" y-max="86.0" y-min="77.0"><inno:nec bbox="77.8 663.74 83.31 668.02" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The below focuses on a few aspects of the expectations for NGMs.</inno:font></inno:block></inno:text><inno:text id="text-221" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="281.0" x-min="45.0" y-max="94.9" y-min="86.1"><inno:nec bbox="77.8 649.04 83.31 653.32" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Issuers should refer to the guidance in SN 52-306 in preparing disclosure documents</inno:font></inno:block></inno:text><inno:text id="text-222" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="117.0" x-min="45.0" y-max="103.0" y-min="95.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">NGMs in a News Release</inno:font></inno:block></inno:text><inno:text id="text-223" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="340.0" x-min="55.0" y-max="124.0" y-min="109.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">COMPANY ABC REPORTS NET EARNINGS OF $5 MILLION AND ADJUSTED EBITDA OF $14<inno:br/>MILLION</inno:font></inno:b></inno:block></inno:text><inno:text id="text-224" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="257.0" x-min="45.0" y-max="141.0" y-min="133.0"><inno:nec bbox="77.8 577.03 82.39 580.6" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Net Earnings decreased 58% from the same period in the prior year to $5M</inno:font></inno:block></inno:text><inno:text id="text-225" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="276.0" x-min="45.0" y-max="150.0" y-min="141.1"><inno:nec bbox="77.8 564.73 82.39 568.3" cid="1" code="0xf0b7" fid="21:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Adjusted EBITDA decreased 12% from the same period in the prior year to $14M.</inno:font></inno:block></inno:text><inno:text id="text-226" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="186.0" y-min="156.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">* Adjusted EBITDA is a Non-GAAP Financial Measure adjusted to exclude amounts that are outside the<inno:br/>Company’s normal activities. For more information, refer to the section on Non-GAAP Financial Measures at the<inno:br/>end of this news release, and below for a reconciliation of adjusted EBITDA to the most comparable GAAP<inno:br/>measure.</inno:font></inno:block></inno:text><inno:table id="table-19" type="table"><inno:block page="26" page-height="512" page-width="396" x-max="244.0" x-min="45.0" y-max="332.0" y-min="194.0"><inno:tr row="1">
<inno:td col="1" id="table-19-1-1" x-max="165.5" x-min="45.0" y-max="208.0" y-min="194.0"/>
<inno:td col="2" id="table-19-1-2" x-max="200.5" x-min="165.5" y-max="208.0" y-min="194.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>XX, 2020</inno:u></inno:font></inno:td>
<inno:td col="3" id="table-19-1-3" x-max="244.0" x-min="200.5" y-max="208.0" y-min="194.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>XX, 2019</inno:u></inno:font></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-19-2-1" x-max="165.5" x-min="45.0" y-max="226.5" y-min="208.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Net earnings</inno:font></inno:td>
<inno:td col="2" id="table-19-2-2" x-max="200.5" x-min="165.5" y-max="226.5" y-min="208.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$5M</inno:font></inno:td>
<inno:td col="3" id="table-19-2-3" x-max="244.0" x-min="200.5" y-max="226.5" y-min="208.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$12M</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-19-3-1" x-max="165.5" x-min="45.0" y-max="242.0" y-min="226.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Interest</inno:font></inno:td>
<inno:td col="2" id="table-19-3-2" x-max="200.5" x-min="165.5" y-max="242.0" y-min="226.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$2M</inno:font></inno:td>
<inno:td col="3" id="table-19-3-3" x-max="244.0" x-min="200.5" y-max="242.0" y-min="226.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$1M</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-19-4-1" x-max="165.5" x-min="45.0" y-max="257.5" y-min="242.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Depreciation</inno:font></inno:td>
<inno:td col="2" id="table-19-4-2" x-max="200.5" x-min="165.5" y-max="257.5" y-min="242.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>$3M</inno:u></inno:font></inno:td>
<inno:td col="3" id="table-19-4-3" x-max="244.0" x-min="200.5" y-max="257.5" y-min="242.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt"><inno:u>$3M</inno:u></inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-19-5-1" x-max="165.5" x-min="45.0" y-max="272.5" y-min="257.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">EBITDA</inno:font></inno:td>
<inno:td col="2" id="table-19-5-2" x-max="200.5" x-min="165.5" y-max="272.5" y-min="257.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$10M</inno:font></inno:td>
<inno:td col="3" id="table-19-5-3" x-max="244.0" x-min="200.5" y-max="272.5" y-min="257.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$16M</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-19-6-1" x-max="165.5" x-min="45.0" y-max="297.0" y-min="272.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Restructuring costs related to COVID-19<inno:br/>(1)</inno:font></inno:td>
<inno:td col="2" id="table-19-6-2" x-max="200.5" x-min="165.5" y-max="297.0" y-min="272.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$4M</inno:font></inno:td>
<inno:td col="3" id="table-19-6-3" x-max="244.0" x-min="200.5" y-max="297.0" y-min="272.5"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">-</inno:font></inno:td>
</inno:tr>
<inno:tr row="7">
<inno:td col="1" id="table-19-7-1" x-max="165.5" x-min="45.0" y-max="311.0" y-min="297.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Government subsidies (2)</inno:font></inno:td>
<inno:td col="2" id="table-19-7-2" x-max="200.5" x-min="165.5" y-max="311.0" y-min="297.0"><inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">$(2M)</inno:font></inno:td>
<inno:td col="3" id="table-19-7-3" x-max="244.0" x-min="200.5" y-max="311.0" y-min="297.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">-</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="8">
<inno:td col="1" id="table-19-8-1" x-max="165.5" x-min="45.0" y-max="332.0" y-min="311.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">ADJUSTED EBITDA</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-19-8-2" x-max="200.5" x-min="165.5" y-max="332.0" y-min="311.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">$12M</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-19-8-3" x-max="244.0" x-min="200.5" y-max="332.0" y-min="311.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">$16M</inno:font></inno:b></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-227" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="399.0" y-min="338.0"><inno:font font-name="ArialMT" font-size="8.50pt">1.</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">As a result of the COVID-19 pandemic, management expects decreased demand for our products for the<inno:br/>remainder of 2020 and 2021. As a result, management has reorganized its operations to streamline<inno:br/>production and reduce head office staff. These restructuring costs include the cost of laying off XX<inno:br/>employees and the cost of shifting the majority of the production to manufacturing plant A. Additional<inno:br/>restructuring costs are expected in Q1,2021, although the majority of the restructuring costs have already<inno:br/>been incurred. Please refer to the COVID-19 impact section of the company’s MD&amp;A and the restructuring<inno:br/>costs note in the financial statements, filed concurrently with this news release, for additional details on the<inno:br/>impact of COVID-19 on the company’s operations.</inno:font></inno:block></inno:text><inno:text id="text-228" type="text"><inno:block page="26" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="428.0" y-min="405.0"><inno:font font-name="ArialMT" font-size="8.50pt">2.</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">The Company received government assistance from the Canada Emergency Wage Subsidy program<inno:br/>(CEWS). During Q3, 2020, the Company recorded $2M of wage subsidies as a reduction of salary expenses.<inno:br/>More information about government assistance is included in the MD&amp;A.</inno:font></inno:block></inno:text><inno:text id="text-229" type="text"><inno:block page="27" page-height="512" page-width="396" x-max="204.0" x-min="191.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-29-</inno:font></inno:block></inno:text><inno:text id="text-230" type="text"><inno:block page="27" page-height="512" page-width="396" x-max="79.0" x-min="43.0" y-max="52.0" y-min="44.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="12.00pt">Questions</inno:font></inno:b></inno:block></inno:text><inno:text id="text-231" type="text"><inno:block page="27" page-height="512" page-width="396" x-max="206.0" x-min="43.0" y-max="72.0" y-min="58.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Please refer your questions to any of the following:</inno:font></inno:block></inno:text><inno:table id="table-20" type="table"><inno:block page="27" page-height="512" page-width="396" x-max="371.0" x-min="45.0" y-max="342.0" y-min="75.0"><inno:tr row="1">
<inno:td col="1" id="table-20-1-1" x-max="189.5" x-min="45.0" y-max="124.0" y-min="75.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Jodie Hancock<inno:br/>Senior Accountant, Corporate Finance<inno:br/>Ontario Securities Commission<inno:br/>416-593-2316</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>j</inno:u></inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt"><inno:u>hancock</inno:u></inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>@osc.gov.on.ca</inno:u></inno:font></inno:color></inno:td>
<inno:td col="2" id="table-20-1-2" x-max="371.0" x-min="189.5" y-max="124.0" y-min="75.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Stacy Cao<inno:br/>Accountant, Corporate Finance<inno:br/>Ontario Securities Commission<inno:br/>416-597-7246</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>scao@osc.gov.on.ca</inno:u></inno:font></inno:color></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-20-2-1" x-max="189.5" x-min="45.0" y-max="172.0" y-min="124.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Allan Lim<inno:br/>Manager<inno:br/>British Columbia Securities Commission<inno:br/>604-899-6780</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>alim@bcsc.bc.ca</inno:u></inno:font></inno:color></inno:td>
<inno:td col="2" id="table-20-2-2" x-max="371.0" x-min="189.5" y-max="172.0" y-min="124.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Anthony Potter<inno:br/>Manager, Corporate Disclosure &amp; Financial Analysis<inno:br/>Alberta Securities Commission<inno:br/>403-297-7960</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>Anthony.Potter@asc.ca</inno:u></inno:font></inno:color></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-20-3-1" x-max="189.5" x-min="45.0" y-max="184.05" y-min="172.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Heather Kuchuran</inno:font></inno:td>
<inno:td col="2" id="table-20-3-2" rowspan="5" x-max="371.0" x-min="189.5" y-max="217.5" y-min="172.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Wayne Bridgeman<inno:br/>Deputy Director, Corporate Finance<inno:br/>Manitoba Securities Commission<inno:br/>204-945-4905</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>wayne.bridgeman@gov.mb.ca</inno:u></inno:font></inno:color></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-20-4-1" x-max="189.5" x-min="45.0" y-max="192.5" y-min="184.05"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Director, Corporate Finance</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-20-5-1" x-max="189.5" x-min="45.0" y-max="201.0" y-min="192.5"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Financial and Consumer Affairs Authority of</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-20-6-1" x-max="189.5" x-min="45.0" y-max="209.05" y-min="201.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Saskatchewan</inno:font></inno:td>
</inno:tr>
<inno:tr row="7">
<inno:td col="1" id="table-20-7-1" x-max="189.5" x-min="45.0" y-max="217.5" y-min="209.05"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">306-787-1009</inno:font></inno:td>
</inno:tr>
<inno:tr row="8">
<inno:td col="1" id="table-20-8-1" x-max="189.5" x-min="45.0" y-max="230.0" y-min="217.5"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>heather.kuchuran@gov.sk.ca</inno:u></inno:font></inno:td>
<inno:td col="2" id="table-20-8-2" x-max="371.0" x-min="189.5" y-max="230.0" y-min="217.5"/>
</inno:tr>
<inno:tr row="9">
<inno:td col="1" id="table-20-9-1" x-max="189.5" x-min="45.0" y-max="279.5" y-min="230.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Nadine Gamelin<inno:br/>Senior Analyst, Financial Information<inno:br/>Autorité des marchés financiers<inno:br/>514-395-0337, ext. 4417</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>nadine.gamelin@lautorite.qc.ca</inno:u></inno:font></inno:color></inno:td>
<inno:td col="2" id="table-20-9-2" x-max="371.0" x-min="189.5" y-max="279.5" y-min="230.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Geneviève Laporte<inno:br/>Analyst, Financial Information<inno:br/>Autorité des marchés financiers<inno:br/>514-395-0337</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>genevieve.laporte@lautorite.qc.ca</inno:u></inno:font></inno:color></inno:td>
</inno:tr>
<inno:tr row="10">
<inno:td col="1" id="table-20-10-1" x-max="189.5" x-min="45.0" y-max="299.05" y-min="279.5"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Frank McBrearty<inno:br/>Senior Legal Counsel</inno:font></inno:td>
<inno:td col="2" id="table-20-10-2" rowspan="2" x-max="371.0" x-min="189.5" y-max="342.0" y-min="279.5"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Junjie (Jack) Jiang<inno:br/>Securities Analyst, Corporate Finance<inno:br/>Nova Scotia Securities Commission<inno:br/>902-424-7059<inno:br/>jack.jiang@novascotia.ca</inno:font></inno:td>
</inno:tr>
<inno:tr row="11">
<inno:td col="1" id="table-20-11-1" x-max="189.5" x-min="45.0" y-max="342.0" y-min="299.05"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Financial and Consumer Services Commission<inno:br/>(New Brunswick)<inno:br/>506-658-3119</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt"><inno:u>Frank.McBrearty@fcnb.ca</inno:u></inno:font></inno:color></inno:td>
</inno:tr>
</inno:block></inno:table></inno:content></inno:dom>